Podcasts about Beth Israel Hospital

Barrett J. Rollins, MD, PhD, received his doctoral degree in 1979 and medical degree in 1980 from Case Western Reserve University and completed his internship and residency in internal medicine at Beth Israel Hospital, Boston. He then performed clinical and research fellowships in medical oncology at Dana-Farber and joined the Institute's faculty in 1986. Dr. Rollins served as Dana-Farber's Chief Scientific Officer from 2004-2019; he is currently Professor of Medicine at Harvard Medical School and a senior advisor to Dana-Farber's President and CEO.

Michael Wallace has the top stories from the WCBS newsroom.

Dr. Augustus A. White III is an American surgeon who is the Ellen and Melvin Gordon Distinguished Professor of Medical Education and Professor of Orthopedic Surgery at Harvard Medical School and a former Orthopedic Surgeon-in-Chief at Beth Israel Hospital in Boston, Massachusetts. He was the President and Co-founder of the J. Robert Gladden Society, whose mission “is to increase diversity within the orthopedic profession and promote the highest quality musculoskeletal care for all people. This episode uncovers how he become the first African American medical student at Stanford, surgical resident at Yale University, Professor of medicine at Yale, and department head at a Harvard-affiliated hospital, Beth Israel Hospital. To hear more about his story make sure you tune in to another Black Men in Medicine Podcast episode, bringing you nothing but the gems! --- Support this podcast: https://podcasters.spotify.com/pod/show/blackmeninmedicine/support

New city data shows New Yorkers are more likely to have been killed by a driver than a gunman this year, with 127 people killed by drivers since January. Also, New York Philharmonic President and CEO Gary Gintsling resigned on Thursday after just one year on the job. And in Queens, Rockaway Beach reopens Friday after shark sightings forced authorities to close a stretch on Thursday. Plus, Beth Israel Hospital in Downtown Manhattan is not closing this week despite initial plans to shut down by July 12. The hospital is serving a fraction of its former patient load, and officials say they still hope to close soon. WNYC's Michael Hill speaks with health care reporter Caroline Lewis to explain the situation. Finally, as Democrats clash over President Biden's candidacy, WNYC's Brigid Bergin talks to retired New York Democrats about how they made the decision to relinquish power.

Susy and Steve talk with author and TV presenter Rev. Michael JS. Carter (They forget to tell Andy...)Rev. Michael JS. Carter is originally from Baltimore, Maryland. He moved to New York City in 1980 and lived there for 27 years. Michael is an ordained Interfaith Minister and received his BA Degree in Letters from the College of New Rochelle, where he graduated cum laude. He received his Masters In Divinity Degree from Union Theological Seminary in NewYork City (class of 2000). He has served as a staff chaplain (Board Certified) at Lenox Hill Hospital, Beth Israel Hospital, Beth Israel Cancer Center, Methodist Hospital, and New York Hospital Queens while residing in New York City. While serving various Unitarian Universalist Congregations in New York, Michael was trained as an anti-racism trainer and has been recognized by President Clinton for his efforts.Michael was also a weekly columnist for the Asheville Citizen Times, and has written articles for the Black Mountain News, and The Tryon Daily Bulletin, both local North Carolina Newspapers .A long-time UFO Contactee, his Book Alien Scriptures: Extraterrestrials In The Holy Bible was in March of 2014) number one on Amazon.com's list of UFO-related books. Michael has also appeared on George Noory's Coast To Coast radio show and on George Noory's TV show, “Beyond Belief” on Gaiam Television. He has also appeared as a regular guest on Midnight In the Desert, with host Heather Wade. Ms. Wade has taken over for Mr. Art Bell. His credits also include appearing on Academy Award-winning actress Shirley Maclaine's radio show, as well as author Whitley Strieber's radio show, “Unknown Country.” Michael also appeared this past July 2016 as a guest speaker at the Phoenix MUFON gathering. Michael has written articles on the topic of UFOs and Religion for such publications as UFO Magazine, Alien Encounters (A British Publication), The MUFON UFO Journal, Contact Forum, The S.P.A.C.E. (Support Program for Abductees Contact Encounters) which is a UFO experiencer support group in New York City. He has also spoken at various UFO Confereneces, such as the Second Philadelphia Need To Know Conference, The Annual Long Island UFO Conference with the late Budd Hopkins, as well as appearing on radio and TV shows across the Nation. Rev. Carter has also appeared on Japanese TV talking about UFOs and The Bible. Other TV appearances include being a regular consultant on The History Channel's, Ancient Aliens Series, as well as being featured in the UFO TV Documentary, The Real 4400. Rev. Carter was also featured in Steven Spielberg”s TV documentary, Abduction Diaries, for the Sci-Fi Channel. “Diaries” was the precursor to Spielberg's HBO series, “Taken.” Become a supporter of this podcast: https://www.spreaker.com/podcast/paranormal-uk-radio-network--4541473/support.

I love talking about metacognition, in hopes of improving how I think, how I diagnose, and how I learn. Dr. Smoller loves to teach and is interested in learning theory, and he has active research experience in learning/teaching visual recognition through pattern recognition, fast thinking. And yet, algorithmic thinking (slow thinking) is important, too. Our conversation is based on a lecture he gave at the recent March, 2024 International Society of Dermatopathology meeting. Don't miss this conversation! Dr. Bruce Smoller MD trained in anatomic and clinical pathology at Harvard's Beth Israel Hospital and in dermatopathology with Dr. Scott McNutt at Cornell Medical School/ New York Hospital. He has worked at Stanford University, rising to the rank of Professor of Pathology and Dermatology as well as at the University of Arkansas, where he was Chair of the Department of Pathology and the Director of Dermatopathology from 1997 to 2011. In 2011, he became Executive Vice President of the United States and Canadian Academy of Pathology. Since 2014, he has been Professor and Chair, Department of Pathology and Laboratory Services and Professor of Dermatology at the University of Rochester School of Medicine and Dentistry. Dr. Smoller is a former Editor-in-Chief of the Journal of Cutaneous Pathology and served as the President of the American Society of Dermatopathology, receiving the Nickel Award, which recognizes lifetime excellence in teaching, from the American Society of Dermatopathology. He received a Lifetime Achievement Award from the College of American Pathologists in 2022. He has written over 300 articles and has primary involvement in 18 books.

Three magic words to help conquer fear, that may also be a secret to having a long and productive career. I really enjoyed this conversation with Dr. Bruce Smoller, a giant in the field of dermatopathology and pathology. Also tune in next week for Part 2! Dr. Bruce Smoller MD trained in anatomic and clinical pathology at Harvard's Beth Israel Hospital and in dermatopathology with Dr. Scott McNutt at Cornell Medical School/ New York Hospital. He has worked at Stanford University, rising to the rank of Professor of Pathology and Dermatology as well as at the University of Arkansas, where he was Chair of the Department of Pathology and the Director of Dermatopathology from 1997 to 2011. In 2011, he became Executive Vice President of the United States and Canadian Academy of Pathology. Since 2014, he has been Professor and Chair, Department of Pathology and Laboratory Services and Professor of Dermatology at the University of Rochester School of Medicine and Dentistry. Dr. Smoller is a former Editor-in-Chief of the Journal of Cutaneous Pathology and served as the President of the American Society of Dermatopathology, receiving the Nickel Award, which recognizes lifetime excellence in teaching, from the American Society of Dermatopathology. He received a Lifetime Achievement Award from the College of American Pathologists in 2022. He has written over 300 articles and has primary involvement in 18 books.

Dr. Drew Weissman, M.D., Ph.D., ( https://www.med.upenn.edu/apps/faculty/index.php/g275/p20322 ) is a 2023 Nobel Laureate in Medicine ( https://www.nobelprize.org/prizes/medicine/2023/summary/ ), Roberts Family Professor in Vaccine Research and Director of the Penn Institute for RNA Innovation ( https://rnainnovation.med.upenn.edu/ ). He is also a Professor in the Department of Medicine and Director of Vaccine Research in the Infectious Diseases Division at the Perelman School of Medicine at the University of Pennsylvania ( https://www.pennmedicine.org/providers/profile/drew-weissman ). Dr. Weissman is a physician-scientist and pioneer in the science of immunology, with major contributions to the field. Most notably, Dr. Weissman, and his colleagues discovered a novel nucleoside-modified mRNA platform that bypasses adverse immunologic response, which was the result of decades-long dedication and research, not just focused on modifying mRNA, but also developing a novel lipid nanoparticle delivery technique, ensuring that it could reach the proper part of the body and trigger the immune system to fight disease. This platform not only serves as the basis for the burgeoning research of targeted therapeutics for some of the world's most devastating diseases, but paved the way for the first mRNA vaccines, being the critical backbone to the COVID-19 mRNA vaccines. Dr. Weissman and his lab team ( https://www.med.upenn.edu/weissmanlab/ ) continue to conduct basic science research to understand and develop new nucleoside-modified mRNA platforms to advance effective and safe vaccines for different types of diseases, as well as new therapeutics. Dr. Weissman and his team are currently at work on a variety of novel projects such as a pan-coronavirus vaccine to stop the next coronavirus epidemic, a universal flu vaccine, and a vaccine to prevent herpes, as well as working with Penn colleagues to develop interventions in various non-communicable diseases, such as cancer therapeutics with mRNA technology. Dr. Weissman's lab is also developing a SARS-CoV-2 mRNA vaccine with Chulalongkorn University in Thailand to help residents of Thailand and other surrounding nations with fewer financial resources than the United States access lifesaving vaccines. Before joining Penn in 1997, Dr. Weissman was a fellow at the National Institutes of Health studying HIV in the immunoregulation lab of Dr. Anthony Fauci. Dr. Weissman received his bachelor's degree and master's degree from Brandeis University, majoring in biochemistry and enzymology, and earned his MD and PhD working in immunology and microbiology at Boston University and completed his residency at Beth Israel Hospital. Support the show

Dr. Singleton, a Board-Certified Anesthesiologist and constitutional lawyer discusses the power of the patient to find quality, affordable, and individualized healthcare by seeking care with an independent physician. Dr. Singleton is a board-certified anesthesiologist and past president of the Association of American Physicians and Surgeons. She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at the University of California at San Francisco Medical Center, and her Anesthesia residency at Harvard's Beth Israel Hospital. She was on the faculty at Johns Hopkins Hospital in Baltimore, Maryland, before returning to California for private practice. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional and administrative law. She interned at the National Health Law Project, and practiced insurance and health law. Dr. Singleton has published numerous articles, given presentations on health policy, and had many radio and television appearances, and a monthly radio show, Health Freedom Now. She started a blood pressure screening clinic at her church and make-shift clinics in two rural villages in El Salvador. Dr. Singleton ran for Congress in 2012 with a message of personal freedom and limited government. [Marilyn Singleton – Visit Her Website] • [America Out Loud – Listen to Dr. Singleton on Mondays]  

The NYPD is preparing for protests related to the ongoing Israel-Hamas war during the Rockefeller Center Christmas Tree lighting. Also, Mount Sinai Health officials defended their plan to shut down Beth Israel Hospital at a heated community forum in Manhattan on Tuesday. Meanwhile, the city's recent crackdown on unlicensed vendors has reached Prospect Park's farmers market in Brooklyn. Plus, worried landlords across New York City are banning tenants from storing e-bikes in their buildings for fear of lithium battery fires. Finally, WNYC's Community Partnerships desk regularly teams up with the nonprofit, Street Lab, to collect and share stories from neighborhoods across the five boroughs. Our latest stop is in Brooklyn's Kensington neighborhood.

In this latest episode of ASTCT Talks, Dr. Rahul Banerjee, MD, FACP, sits down with Dr. Amrita Krishnan, MD. They delve into the use of GPRC5D as a target in myeloma therapy, specifically focusing on Talquetamab. Dr. Krishnan shares insights from the MonumenTAL-1 trial, discussing the dosing schedules and response rates with GPRC5D-targeted therapy. They explore the unique toxicities associated with this treatment, such as cytokine release syndrome and skin and nail toxicities. The conversation also touches on the considerations for patients who have previously received BCMA-targeted therapies and the potential of GPRC5D-targeted therapy in improving outcomes. Tune in to learn about the evolving landscape of myeloma treatment beyond BCMA. About Dr. Rahul Banerjee, MD, FACP Dr. Rahul Banerjee, MD, FACP, (@RahulBanerjeeMD) is an Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington. His clinical interests are in multiple myeloma and CAR-T therapy. He has authored over 60 peer-reviewed publications with a research emphasis on reducing toxicities and improving the patient experience during treatment for multiple myeloma. About Dr. Amrita Krishnan, MD Dr. Amrita Krishnan, MD (@DoctorAKrishnan) directs the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope, seeking to make gains in one of the most rapidly changing areas in cancer research. A key member of the City of Hope team since 1996, Dr. Krishnan trained at The University of Rochester, Beth Israel Hospital, Fred Hutchinson Research Cancer Center and Dana Farber Cancer Institute. She serves as a steering committee member on the Multiple Myeloma Research Foundation and the North American representative to the International Myeloma Society, former chair of the Blood and Marrow Transplant Clinical Trials Network myeloma committee and is the Co-Chair of several of the largest myeloma transplant trials in the U.S. Her research interests are in development of new drugs for relapsed myeloma and understanding mechanisms of disease resistance.

This week on The Mommy Labor Nurse Podcast, I'm honored to have a distinguished guest, Dr. Wanda Barfield, joining us in support of the CDC's Hear Her Campaign. This initiative aims to raise awareness about maternal health issues and promote respectful maternity care. The CDC has recently released its 2023 Vital Signs Report, shedding light on crucial statistics and findings related to maternal care in the United States. During our time with Dr. Barfield, we'll explore the report's insights, discuss the importance of addressing mistreatment during pregnancy and delivery, and learn how the Hear Her campaign is working to improve communication between healthcare providers and pregnant and postpartum patients. Want to feel more in control of your birth experience? No matter how you plan to deliver, the FREE Birth Prep Guide is here to help you prepare. Have an even better birth! CLICK HERE to learn more about our online birth classes that will help you feel prepared and in control - no matter how you deliver. And be sure to follow @mommy.labornurse on Instagram to join our community of over half a million for education, tips, and solidarity on all things pregnancy, birth, and postpartum! About Dr. Wanda Barfield Wanda Barfield, MD, MPH, FAAP, is the Director of the Division of Reproductive Health (DRH) within the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) at the Centers for Disease Control and Prevention (CDC). She also serves as Assistant Surgeon General in the U.S. Public Health Service. She received her medical and public health degrees from Harvard University and completed a pediatrics residency at Walter Reed Army Medical Center and a neonatal-perinatal medicine fellowship at Harvard's Joint Program in Neonatology (Brigham and Women's Hospital, Beth Israel Hospital, and Children's Hospital, Boston). Before joining CDC in 2000, she was Director of the Neonatal Intensive Care Unit at Madigan Army Medical Center in Tacoma, Washington. She is also an Adjunct Assistant Professor at Emory University School of Medicine. She is a Fellow with the American Academy of Pediatrics (AAP) and is the CDC liaison to the AAP Section on Perinatal Pediatrics (SoPPe) and Committee on Fetus and Newborn (COFN). She continues to do clinical work in neonatology, providing care to critically ill newborns in Atlanta, Georgia.  

Frank Morano discusses some of the hottest topics and gives his opinion. Frank talks about the migrant situation in Staten Island and then Frank talks about the slashing of NYPD services. Frank discusses the closing of Beth Israel Hospital and then Frank talks about parents in Putnam County speaking out against Seniors painting their parking spots in a High School parking lot. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Karl Singer is a family physician and geriatrician who recently retired from active practice in Exeter, NH. Over more than 40 years in practice, he has seen enormous changes in the patterns of illness in his older patients. The changes reflect both advances in medical care and a new understanding of the importance of lifestyle on illness and quality of life.In this episode, Dr. Singer will discuss strategies for optimizing health and function in older adults based on current research. He will also outline some of the challenges of the new frontier of caring for patients in their 80s and 90s and attempting to maximize function in these patients.When you tune in, you should have a better idea of the steps you and your patients or clients can take to remain active and engaged through the fourth and fifth age.About Karl Singer:Dr. Singer graduated from Harvard Medical School in 1967 and completed his training in medicine at Beth Israel Hospital in Boston in 1972. Since then, he has practiced as a primary care physician in Exeter, NH. He recently retired from his office-based practice. Dr. Singer is board-certified in Family Medicine and Geriatrics as well as Internal Medicine and is a Fellow of the American College of Physicians and the American Academy of Family Practice.Dr. Singer's interest in older adults began when he joined the staff of Rockingham Nursing Home, a 220-bed county facility, in 1975. Dr. Singer has over 200 publications on a wide variety of medical topics. He has been the chairman of the education committee at Exeter Hospital for more than 30 years and has taught at Harvard Medical School and Ben Gurion University of the Negev in Beer Sheva, Israel.Get in touch with Karl Singer:Karl's LinkedIn Profile: https://www.linkedin.com/in/karl-singer-b6609425/ What to do next: Click to grab our free guide, 10 Key Issues to Consider as You Explore Your Retirement Transition Please leave a review at Apple Podcasts. Join our Revolutionize Your Retirement group on Facebook.

New York City Comptroller Brad Lander still has serious concerns about DocGo, a medical services provider tasked with helping migrants. Plus, Mount Sinai announced it's shutting down Beth Israel Hospital, citing years of financial turmoil. And finally, WNYC's Jon Campbell looks into a few troubling incidents at the Brooklyn Mirage.

Dr. Marilyn Singleton, a Board-Certified Anesthesiologist and the past president of The American Association of Physicians and Surgeons discusses the state of our healthcare system. What can we learn from the past and the present to create a better future?  She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at the University of California at San Francisco Medical Center, and her Anesthesia residency at Harvard's Beth Israel Hospital. She was on the faculty at Johns Hopkins Hospital in Baltimore, Maryland, before returning to California for private practice. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional and administrative law. She interned at the National Health Law Project, and practiced insurance and health law. Dr. Singleton has published numerous articles, given presentations on health policy, and had many radio and television appearances, and a monthly radio show, Health Freedom Now. She started a blood pressure screening clinic at her church and make-shift clinics in two rural villages in El Salvador. Dr. Singleton ran for Congress in 2012 with a message of personal freedom and limited government. [Marilyn Singleton – Visit Her Website] • [America Out Loud – Listen to Dr. Singleton on Mondays]

Synopsis: Andrew Scharenberg is the Co-founder and CEO of Umoja Biopharma, a company pioneering the future of immunotherapy by reprogramming T cells in vivo. Umoja's groundbreaking integrated platform therapeutics reprogram the immune system in the patient's body to target cancer cells and generate lasting remissions. Andrew talks about the CAR T-cell therapy space, the opportunities he sees, and how he sees the space evolving over the next two decades. He discusses the work that his team is pursuing at Umoja to develop a new approach to cancer therapy that retools a patient's immune system in vivo, enhancing the body's natural capacity to fight cancer, and where the company is from a development perspective. He also talks about how he thinks about indication selection, particularly in the early stages of biotech. Finally, he shares how the pandemic impacted his approach to team building and his thoughts on distributed teams. Biography: Dr. Andrew M. Scharenberg is the founder and CEO of Umoja Biopharma, an MPM portfolio company. He also serves as an Executive Partner at MPM Capital, and Chairs the Scientific Advisory Boards at Generation Bio, Genti Bio, and Alpine Immune Sciences. Prior to founding Umoja, Andrew co-directed the Program in Cell and Gene Therapy at Seattle Children's Research Institute, working to translate cell and gene therapies for the treatment of inherited immunologic and blood diseases. This work led to the development of a program in engineered regulatory T-cells, partnered with Casebia Therapeutics for the purpose of developing a gene edited cell therapeutic for Type I diabetes and other inflammatory diseases. Previously, he was the Chief Scientific Officer of Cellectis Therapeutics, where he initiated the development of an allogeneic CAR T-cell platform, and co-founder of Pregenen Inc., a gene editing and cell-signalling technology company that was acquired by bluebird bio in 2014. Andrew earned his M.D. from the University of North Carolina School of Medicine, and then completed residency at the University of North Carolina Children's Hospital and his fellowship in immunology at NIH and at the Division of Experimental Pathology, Beth Israel Hospital. From 2000 to 2020, he was an attending Physician at Seattle Children's Hospital, a Professor in the Department of Pediatrics, and an Adjunct Professor in the Department of Immunology at the University of Washington School of Medicine in Seattle. Andrew received the American Pediatric Society/Society for Pediatric Research National Young Investigator Award in 2002. He is an active member of the American Society for Clinical Investigation and the American Pediatric Society.

Dr. Marilyn Singleton, M.D., a Board-Certified Anesthesiologist, and the past president of The American Association of Physicians and Surgeons joins Dr. George for a frank discussion about the state of our healthcare system. Dr. Singleton graduated from Stanford and earned her MD at UCSF Medical School. She completed 2 years of Surgery residency at the University of California at San Francisco Medical Center, and her Anesthesia residency at Harvard's Beth Israel Hospital. She was on the faculty at Johns Hopkins Hospital in Baltimore, Maryland, before returning to California for private practice. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional and administrative law. She interned at the National Health Law Project, and practiced insurance and health law. Dr. Singleton has published numerous articles, given presentations on health policy, and had many radio and television appearances, and a monthly radio show, Health Freedom Now. She started a blood pressure screening clinic at her church and make-shift clinics in two rural villages in El Salvador. Dr. Singleton ran for Congress in 2012 with a message of personal freedom and limited government. [Marilyn Singleton – Visit Her Website] • [America Out Loud – Listen to Dr. Singleton on Mondays]

Dr. Jordan B. Peterson and Miriam Grossman discuss the grief and trauma associated with the Transgender movement, not just for those transitioning, but for the parents and families who now find themselves shunned and alienated if they refuse to affirm their own child's delusion. They also go into detail on the history of the ideology, the monstrosity of Dr. John Money, and his horrendous failed experiment on which he built his doctrines. Miriam Grossman MD is a physician, author, and public speaker. Before gender ideology was on anyone's radar, she warned parents about its dangers in her 2009 book, “You're Teaching My Child WHAT?” Dr. Grossman has been vocal for many years about the capture of her profession by ideologues, leading to dangerous and experimental treatments on children and betrayal of parents. Dr. Grossman was featured in the Daily Wire's hit documentary “What Is A Woman?” The author of four books, her work has been translated into eleven languages. After graduating with honors from Bryn Mawr College, Dr. Grossman attended New York University Medical School.  She completed an internship in pediatrics at Beth Israel Hospital in New York City, and a residency in psychiatry through Cornell University Medical College, followed by a fellowship in child and adolescent psychiatry. Dr. Grossman is board certified in psychiatry and in the sub-specialty of child and adolescent psychiatry. - Links - For Miriam Grossman MD: Lost in TransNation (Book) - https://www.amazon.com/Lost-Trans-Nation-Psychiatrists-Madness/dp/1510777741 You're Teaching My Child WHAT? (Book) - https://www.amazon.com/Youre-Teaching-Child-What-Physician/dp/1596985542 Website - https://www.miriamgrossmanmd.com/  Twitter - https://twitter.com/miriam_grossman?lang=en

Richard P. Shannon, MD serves as theChief Quality Officer for Duke Health. He is responsible for the overalldirection, leadership and operational management of the quality and safetyprograms of Duke Health and provides leadership in strengthening a qualityculture where everyone is engaged and respected.Shannon received his BA from Princeton University and his MDfrom the University of Connecticut School of Medicine. He completed histraining in internal medicine at Beth Israel Hospital, his cardiovasculartraining at Massachusetts General Hospital, and was the Francis Weld PeabodyFellow and Associate Professor of Medicine at Harvard Medical School beforebecoming the Claude R. Joyner Professor of Medicine at Drexel UniversityCollege of Medicine.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Today we spoke with Dr. Ed Park author of the book Telomere Timebombs (I highly recommend it!) and he's also the man behind the product TA-65 which we talked about along with his other product Recharge, which we are going to start taking soon. We'll report back to you as to our experience with it. We were turned on to Dr. Park from a listener and when I began to research the work that he's doing, I was highly impressed and immediately became excited to introduce him to all of you. Some interesting things to consider about living a very long life span... Are humans able to live until we're 200, 400 or more years old? Imaging living in a healthy, vibrant, strong and youthful body all the way until we're that age? Would you want to do it? [spp-tweet "You don't stop laughing when you grow old, you grow old when you stop laughing. George Bernard Shaw"] It means you'd out live multiple generations of family below you. It's a concept that's inconceivable and maybe that's part of the problem. Because we're so programmed for early death maybe it actually imbues itself deep into the very fibers and strands of our DNA? Maybe this energetic blockage of how long we can live actually affects sub atomic particles which actually cause our telomeres to get snipped off from our DNA because telomerase isn't abundant enough. Maybe I don't know what I'm talking about but it's just a theory. Would you want to live that long? Today we had Dr. Ed Park join us in the studio to talk about telomere activation, anti aging (some people prefer to call it pro youthing) and life extension using a super concentrated ancient Chinese herb called astragalus. Dr. Park was gracious enough to make the drive and come into our studio. After the show was over we talked extensively about what it would mean to live for hundreds of years. Would there be over population? Would there be issues with people running out of money? Would there be a drain on natural resources? These are all topics we discussed at the end of the show. We hope you enjoyed our interview with Dr. Ed Park as much as we did and if you did would you consider clicking "like" and "share" on this page to let your friends and family know about the work he is doing? Kate and I would greatly appreciate that! :) Sponsors For This Episode: Carnivora Superfoods - Target & enhance your immune system with Carnivora supplements to prevent disease and feel amazing. Kate and I highly recommend checking them out! BioAge Superfoods - Kate and I have been taking BioAge superfoods now for quite some time and we don't want to be without it. Their spirulina is incredible. Pick some up today. You'll be glad you did. Show Notes For This Episode: Click here to download the show notes for THIS EPISODE. Commercials During This Episode: Commercial #1 - BioAge Superfoods Commercial #2 - Carnivora Immune System Support Commercial #3 - Qigong Moving Meditation Commercial #4 - Vitamix Blender Commercial #5 - Omron Nebulizer Find Extreme Health Radio On: [include file=showpage-itunes-soundcloud-stitcher.html] Please Subscribe: Subscribe To Our Radio Show For Updates! Other Shows: [include file=show-links.html] Listen to other shows with this guest. Show Date: Wednesday 9/10/2014 Show Guest: Dr. Ed Park Guest Info: Dr. Ed Park, MD, MPH, is a telomere and telomerase expert and founder of Recharge Biomedical. He graduated with honors from Harvard University with BA (Bachelor of Arts) in Biological Anthropology in 1989. Dr. Park received MD (Doctor of Medicine) from Columbia University, College of Physicians and Surgeons, and MPH (Master of Public Health) from Columbia University, School of Public Health, in 1993. He completed internship and residency at Beth Israel Hospital, a teaching hospital of the Harvard Medical School in 1997. Show Topic: D Ed Park, telomere, anti aging, pro youthing,

Podcast guest 585 is Rev. Michael JS Carter. Michael is an ordained Interfaith Minister and received his BA Degree in Letters from the College of New Rochelle where he graduated cum laude. He received his Masters In Divinity Degree from Union Theological Seminary in NewYork City (class of 2000). He has served as a staff chaplain (Board Certified) at Lenox Hill Hospital, Beth Israel Hospital, Beth Israel Cancer Center, Methodist Hospital, and New York Hospital Queens while residing in New York City. While serving various Unitarian Universalist Congregations in New York, Michael was trained as an anti-racism trainer and has been recognized by President Clinton for his efforts. Michael was also a weekly columnist for the Asheville Citizen Times, and has written articles for the Black Mountain News, and The Tryon Daily Bulletin, both local North Carolina Newspapers . A long time UFO Contactee, his Book Alien Scriptures: Extraterrestrials In The Holy Bible, was (in March of 2014) number one on Amazon.com's list of UFO related books. Michael has also appeared on George Noory's Coast To Coast radio show, and on George Noory's TV show, “Beyond Belief” on Gaiam Television. Michael has also appeared this past July 2016 as a guest speaker at the Phoenix MUFON gathering. Michael has written articles for on the topic of UFOs and Religion for such publications as UFO Magazine, Alien Encounters (A British Publication), The MUFON UFO Journal, Contact Forum, The S.P.A.C.E. (Support Program for Abductees Contact Encounters) which is a UFO experiencer support group in New York City. He has also spoken at various UFO Conferences, such as the Second Philadelphia Need To Know Conference, The Annual Long Island UFO Conference with the late Budd Hopkins, as well as appearing on radio and TV shows across the Nation. Rev. Carter has also appeared on Japanese TV talking about UFOs and The Bible. Other TV appearances include being a regular consultant on The History Channel's, Ancient Aliens Series, as well as being featured in the UFO TV Documentary, The Real 4400. Rev. Carter was also feature in Steven Spielberg”s TV documentary, Abduction Diaries for the Sci-Fi Channel. “Diaries” was the precursor to the Spielberg's HBO series, “Taken.” Author Whitely Strieber calls Rev. Carter's first book, Alien Scriptures: Extraterrestrials in The Holy Bible, “the best book ever written on the topic.” His three other books are, A New World If You Can Take iT: God, Extraterrestrials, and The Evolution of Human Consciousness. God Consciousness: A 30 Day Meditation Manual for God Conscious Thinking. His most recent addition is, The Metaphysics of Spiritual Healing and the Power of Affirmative Prayer. All of his books may be purchased at Amazon.com and Barnes& Nobles.com JeffMara Merch https://jeffmara-podcast-store.myshopify.com/ --- Send in a voice message: https://anchor.fm/jeffrey-s-reynolds/message Support this podcast: https://anchor.fm/jeffrey-s-reynolds/support

Listen in as Dr. Ellman and I dig into the BUSINESS OF THE MEDICAL FIELD and how the COVID-19 PANDEMIC has IMPACTED THE EXPERIENCE OF MOTHERHOOD. Dr. Ellman recounts the highs and lows of his career as an OB/GYN and why EMPATHY is the ESSENTIAL skill every doctor needs. Listen to this episode as Dr. Ellman recounts his upbringing and the drive it took to become A WELL RESPECTED PHYSICIAN in South Florida. HARD WORK, PERSEVERANCE, EMPATHY & RESPECT are just a few of the qualities that Dr. Ellman brings to the table that makes him stand out amongst the rest.Dr. Ellman is a Board Certified OB/GYN who established his medical practice in South Florida over 25 years ago. Upon completion of his undergraduate studies at Binghamton University, Dr. Ellman went on to earn his medical degree at Albert Einstein College of Medicine of Yeshiva University. Dr. Ellman completed his internship at Beth Israel Hospital in Boston, Massachusetts- an affiliate of Harvard Medical School- and his residency at North Shore University Hospital in Manhasset, New York- an affiliate of Cornell Medical School. Dr. Ellman treats patients at West Boca Hospital, as well as through his own private practice. CONNECT WITH MATT ROSENTHALInstagram: https://www.instagram.com/mattrosenthal_/Youtube: https://www.youtube.com/channel/UCmN6yR0cuOGs6xBPTeznOeALinkedIn: https://www.linkedin.com/in/matt-rosenthal-mindcore/CONNECT WITH Dr. Ellman:Facebook: facebook.com/womenshealthcarebocaratonInstagram: @womenshealthcarebocaWebsite: obgynofboca.comEmail: dellman@femwell.comDigging In is a podcast that uncovers the secrets to success in life, business, and health. In this weekly show, Matt Rosenthal, CEO and seasoned entrepreneur digs in with guests as they share powerful stories about what it takes to be a success. Everyone has untapped potential, and this podcast delivers a roadmap that will inspire, motivate and educate you on your personal journey. Matt Rosenthal is the President and CEO of Mindcore Technologies. In this position, Matt provides his clients with creative and transformative technology solutions. His passion and experience have a substantial impact on the businesses he works with. Matt also prides himself on being a trusted advisor to his clients as he delivers high-impact and creative ideas, strategic guidance, and thought leadership. Matt's fulfillment as a business owner and advisor lies in the satisfaction he feels when he has made a difference and truly helps others. Visit https://mind-core.com for more information.Be sure to subscribe to the podcast on Spotify!https://open.spotify.com/show/6oiWfrl9pQgUYeDKafUYE2

Let's demystify TMD management and surgical intervention!  Join Chad, JB, and Jeff with their guest, Dr. Brian Shah as he shares his journey and methodology in TMD management.Dr. Brian S. Shah was born in Chicago, Illinois and grew up outside of Cleveland, Ohio. He did his undergraduate studies at Miami University in Oxford, Ohio where he majored in microbiology and received his Bachelor of Arts in 1996. Dr. Shah then completed dental school at The Ohio State University College of Dentistry where he received the Arden K. Hegtvedt research scholarship in the department of Oral and Maxillofacial Surgery. Dr. Shah was lucky enough to do his research with the late Dr. Larry Peterson. During his time at Ohio State, he was also named a Hinman Scholar which was awarded in Atlanta, Georgia. Dr. Shah continued his studies and received his MD from Harvard Medical School in 2003. He did his General Surgery and Oral and Maxillofacial Surgery residencies in the Harvard system. This included rotations at Massachusetts General Hospital, Boston Children's Hospital, The Brigham and Women's Hospital, The Beth Israel Hospital and The Massachusetts Eye and Ear Infirmary. In 2008 Dr. Shah received his Board Certification by The American Board of Oral and Maxillofacial Surgery.Dr. Shah was in academic practice at Yale and maintained a private practice in Chicago prior to joining Dr. Piper. The motivation to join and learn from Dr. Piper was born out of the goal to provide the highest level of care for patients with maxillofacial disharmony and TMJ disorders. The interplay between the joints, the bite and the face cannot be ignored and treating one without addressing the others can lead to sub optimal results. Dr. Shah underwent orthognathic surgery as a sophomore in college and has experienced firsthand how life changing properly executed surgery can be. Dr. Shah's practice is devoted to TMJ surgery and facial reconstruction. By utilizing 3D CT imaging, intra-oral 3D scanning and CAD/CAM technology, Dr. Shah can diagnose and treat facial deformities with unparalleled accuracy. He invites the patient to be part of the treatment planning session which is essential to the co-discovery process. By educating patients on their condition and available treatment options, he has found anxiety can be minimized. Dr. Shah offers procedures such as custom facial implants, Botox and fillers to “touch-up” anything that cannot be accomplished with orthognathic surgery alone.Dr. Shah is teaching faculty for AO.  The AO was founded on November 6, 1958 by a group of Swiss surgeons to champion revolutionary techniques of internal fixation for bone fractures. As faculty, Dr. Shah volunteers his time to teach surgical residents and practicing doctors the AO principles of trauma surgery. His professional affiliations include the American Medical Association, the American Dental Association, the American Association of Oral and Maxillofacial Surgeons, the American College of Oral and Maxillofacial Surgeons, the International Association of Oral and Maxillofacial Surgeons, the American Association of Cosmetic Surgery and the AO.

Season 2 | Episode 26 | June 29, 2022Michael Roizen, MD, chief wellness officer emeritus at the Cleveland Clinic and leading health and wellness communicator, is the guest on Medical Matters Weekly on Wednesday, June 29. The show will address the power of everyday choices in preventing disease and prolonging productive and enjoyable lives.Dr. Roizen began his career with a tour of duty in the Public Health Service. After nine years on the faculty at the University of California, San Francisco, he chaired the top-10-rated Department of Anesthesia and Critical Care at the University of Chicago. He then became dean of the School of Medicine and vice president for Biomedical Sciences at SUNY Upstate. After serving as CEO of the Biotechnology Research Corporation of Central New York, he accepted a position as chair of the Anesthesiology Institute at Cleveland Clinic, responsible for over 180 operatories, 124 critical care beds, and 28 pain therapy-intervention units. In 2007, Dr. Roizen was named chief wellness officer at Cleveland Clinic, the first such position in a major healthcare institution in the United States. Dr. Roizen also served as founding chair of the Wellness Institute at Cleveland Clinic from 2007 to 2017.Dr. Roizen has published 165 peer-reviewed publications and 100 medical textbook chapters and holds 14 US patents. He started six companies, served on Food and Drug Administration (FDA) advisory committees for 16 years, and chaired an FDA advisory committee. He also co-invented a drug, methylnaltrexone (MTNX, trade name Relistor), which received FDA approval for marketing in the United States in 2008. He is most famous for having developed the “RealAge” concept and for authoring and co-authoring five number one New York Times best sellers. He has appeared on leading television and news programs, including The Oprah Winfrey Show, Today, 20/20, and many others and has been featured in many top publications.Dr. Roizen is a Phi Beta Kappa graduate of Williams College in Williamstown, Massachusetts, and an Alpha Omega Alpha graduate of the University of California, San Francisco, School of Medicine. He performed his residency in internal medicine at Harvard's Beth Israel Hospital and completed Public Health Service at the National Institutes of Health in the laboratory of Irv Kopin and Nobel Prize winner Julius Axelrod. He is certified by both the American Boards of Internal Medicine and of Anesthesiology.Medical Matters Weekly features the innovative personalities who drive positive change within health care and related professions. The show addresses all aspects of creating and maintaining a healthy lifestyle for all, including food and nutrition, housing, diversity and inclusion, groundbreaking medical care, exercise, mental health, the environment, research, and government. The show is produced with cooperation from Catamount Access Television (CAT-TV). Viewers can see Medical Matters Weekly on Facebook at facebook.com/svmedicalcenter and facebook.com/CATTVBennington. The show is also available to view or download a podcast on www.svhealthcare.org/medicalmatters.Underwriter: Mack Molding

Dr Michael Cantor studied both Law and Medicine at the University of Illinois, before completing his Residency at Harvard Medical School's Beth Israel Hospital. He is a Geriatrician and has a very interesting career, being the Chief Medical Officer of both Uber Health and Intuition Robotics. We talk about Uber's role in the future of healthcare, the gig economy and hardcore free market economics applied to patients and why it's so important for doctors to be in the driving seat as leaders — not just passive observers. I hope you enjoy. You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Is it possible to save a life with music? It is not only possible but a medical reality as we hear from Andrew Schulman, a professional musician whose near-death experience and miraculous recovery is the subject of his first book, Waking the Spirit. Hear about his harrowing surgical experience during which his vital signs bottomed out causing clinical death, the frantic resuscitation effort and the medically induced coma. As his doctors and nurses agreed he would most likely not survive, his desperate wife found his iPod, placed the earphones on him and hit "PLAY". Within 30 minutes, the St. Matthew Passion by Bach stabilized Andrew's vital signs, reignited his will to live and, with intensive and remarkable care by the doctors and staff at New York's Beth Israel Hospital, slowly brought him back. Thus, he found a new calling--bringing his guitar and musical passion to the bedside of other critically ill patients. Today he is a Certified Medical Musician and a recognized expert on the healing power of music.Support the show

About Rev. Michael J. S. CarterProfessional BioRev. Michael JS.Carter is originally from Baltimore, Maryland. He moved to New YorkCity in 1980 and lived there for 27 years, working as a professional actor before moving to Asheville.Michael is an ordained Interfaith Minister and received his BA Degree in Letters from the College of New Rochelle where he graduated cum laude. He received his Masters In Divinity Degree from Union Theological Seminary in NewYork City (class of 2000). He has served as a staff chaplain (Board Certified) at Lenox Hill Hospital, Beth Israel Hospital, Beth Israel Cancer Center, Methodist Hospital, and New York Hospital Queens while residing in New York City. While serving various Unitarian Universalist Congregations in New York, Michael was trained as an anti-racism trainer and has been recognized by President Clinton for his efforts. Michael was also a weekly columnist for the Asheville Citizen Times, and has written articles for the Black Mountain News, and The Tryon Daily Bulletin, both local North Carolina Newspapers .A long time UFO Contactee, his Book Alien Scriptures: Extraterrestrials In The Holy Bible, was( in March of 2014) number one on Amazon.com's list of UFO related books. Michael has also appeared on George Noory's Coast To Coast radio show, and on George Noory's TV show, “Beyond Belief” on Gaiam Television. He has also appeared as a regular guest on Midnight In the Desert, with host Heather Wade. Ms. Wade has taken over for Mr. Art Bell. He credits also include appearing on Academy Award winning actress, Shirley Maclaine's radio show, as well as author, Whitley Strieber radio show, “Unknown Country.” Michael has also appeared this past July 2016 as a guest speaker at the Phoenix MUFON gathering.Michael has written articles for on the topic of UFOs and Religion for such publications as UFO Magazine, Alien Encounters (A British Publication), The MUFON UFO Journal, Contact Forum, The S.P.A.C.E. (Support Program for Abductees Contact Encounters) which is a UFO experiencer support group in New York City. He has also spoken at various UFO Confereneces, such as the Second Philadelphia Need To Know Conference, The Annual Long Island UFO Conference with the late Budd Hopkins, as well as appearing on radio and TV shows across the Nation. Rev. Carter has also appeared on Japanese TV talking about UFOs and The Bible.Other TV appearances include being a regular consultant on The History Channel's, Ancient Aliens Series, as well as being featured in the UFO TV Documentary, The Real 4400. Rev. Carter was also feature in Steven Spielberg”s TV documentary, Abduction Diaries for the Sci-Fi Channel. “Diaries” was the precursor to the Spielberg's HBO series, “Taken.” Author Whitely Strieber calls Rev. Carter's first book, Alien Scriptures: Extraterrestrials in The Holy Bible, “the best book ever written on the topic.” His three other books are, A New World If You Can Take iT: God, Extraterrestrials, and The Evolution of Human Consciousness. God Consciousness: A 30 Day Meditation Manual for God Conscious Thinking. His most recent addition is, The Metaphysics of Spiritual Healing and the Power of Affirmative Prayer. All of his books may be purchased at Amazon.com and Barnes& Nobles.comMichael is on the advisory board of The Foundation For Research into Extraterrestrial Encounters, or FREE. He also continues to serve a minister for the Unitarian Universalist Congregation of the Swanannoa Valley, located in the beautiful mountains of Western North Carolina, as well as serving as a consulting minister for The Thermal Belt Unitarian Universalist Fellowship in Tryon, North Carolina.

Quantum Nurse www.quantumnurse.lifeinvites you to Freedom International Livestream Jan 11, 2022 @ 12:00 PM EST 5:00 PM UK 6:00 PM Germany Guest: Dr. Marilyn Singleton, MD JD Topic: The Importance of the Hippocratic Oath in Medicine www.marilynsingletonmdjd.com. Brief Bio: Dr. Singleton is a board-certified anesthesiologist and past president of the Association of American Physicians and Surgeons. She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at University of California at San Francisco Medical Center, and her Anesthesia residency at Harvard's Beth Israel Hospital. She was on the faculty at Johns Hopkins Hospital in Baltimore, Maryland before returning to California for private practice at Cedars-Sinai Medical Center in Los Angeles and Alta Bates Medical Center in Berkeley. While still working in the operating room, she attended UC Berkeley Law School focusing on constitutional and administrative law. She interned at the National Health Law Project, and practiced insurance and health law. Dr. Singleton has published numerous articles, given presentations on health policy, and had many radio and television appearances. She recently started hosting a radio show, Health Freedom Now. She teaches classes in the recognition of elder abuse and constitutional law for non-lawyers. Dr. Singleton started a blood pressure screening clinic at her church and make-shift clinics in two rural villages in El Salvador. Dr. Singleton ran for Congress in 2012. Interview Council Grace Asagra, RN MA Podcast: Quantum Nurse: Out of the Rabbit Hole from Stress to Bless https://linktr.ee/GraceAsagra www.quantumnurse.life Hartmut Schumacher Podcast: GO YOUR OWN PATH https://anchor.fm/hartmut-schumacher-path John Katsavos Podcast: The Fitness Oracle https://podcasts.apple.com/us/podcast/the-fitness-oracle/i

Stay younger, longer! Cleveland Clinic's Dr. Michael Roizen on slowing the aging process, the key to longevity, and more  On this Walker Webcast, Willy Walker interviewed Dr. Michael Roizen, on how to live a healthy, happy, and longer life. Dr. Roizen is the New York Times #1 best-selling author of RealAge: Are You as Young as You Can Be? and three other #1's and Chief Wellness Officer Emeritus at the Cleveland Clinic. As we kick-off a New Year, join us to hear how you can live healthier and happier and prepare for the coming (80% probability) reboot so you'll be 40 when the calendar strikes 90. Listen now! ABOUT: Michael F. Roizen, MD, is a Phi Beta Kappa graduate of Williams College and Alpha Omega Alpha graduate of the University of California, San Francisco, School of Medicine who is passionate about helping people choose to live younger and healthier. He performed his residency in internal medicine at Harvard's Beth Israel Hospital and completed Public Health Service at the National Institutes of Health in the laboratory of Irv Kopin and Nobel Prize winner Julius Axelrod. He is certified by both the American Boards of Internal Medicine and of Anesthesiology. Dr. Roizen is the Cofounder of RealAge Inc, which was sold in 2006, but still Chairs its Scientific Advisory Board. He is 72 calendar years of age (2018), but his real age is 53.8. GET NOTIFIED about upcoming shows: » Subscribe to our YouTube channel here: https://www.youtube.com/channel/UC5jhzGBWOTvQku2kLbucGcw » See upcoming guests on the #WalkerWebcast here: https://www.walkerdunlop.com/webcasts/

After graduating from Amherst College, Dr. Rollins received his MD in 1979 and PhD in 1980 from Case Western Reserve University. Dr. Rollins completed his internship and residency in internal medicine at Beth Israel Hospital, Boston.  He then served a clinical fellow in medical oncology at Dana-Farber and a postdoctoral research fellowship with Dr. Charles Stiles.  Since joining Dana-Farber in 1989, Dr.Rollins has worked in the area of white blood cells trafficking and the interactions between inflammation and cancer.  See omnystudio.com/listener for privacy information.

Dr. David Cohen is the Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation in New York, NY. He is also a Professor of Medicine at Columbia University School of Medicine. In addition, he is a practicing interventional and structural cardiologist at St. Francis Hospital in Roslyn, NY as well as their Director of Academic Affairs. Dr. Cohen completed his MD at Harvard Medical School along with a Masters degree in Health Policy at the Harvard School of Public Health. From there, he completed his training in internal medicine at Brigham and Women's Hospital in Boston. Following that, he did his cardiology and interventional cardiology training at Beth Israel Hospital in Boston. In this podcast, Dr. Cohen talks about what it's like to be an interventional and structural cardiologist in addition to being a Director of Academic Affairs and Professor, his unique hobby that helps him relax, and his reasons for getting into cardiology. Dr. Cohen also describes in simple words what occurs during a minimally invasive heart catheterization and a coronary angioplasty procedure. White Coat Story is a podcast series for school students to gain first-person insights into the practice of medicine, and what it takes to get there.

Season 1 | Episode 22 | July 7, 2021In this week's episode, Dr. Trey Dobson hosts Jeffrey Parsonnet, MD, an infectious disease physician at Dartmouth-Hitchcock and the leader of a clinic designed to help people with enduring COVID symptoms. Dr. Parsonnet arrived at Dartmouth in 1990, having completed his Infectious Diseases (ID) training at Brigham and Women's/Beth Israel Hospital.  He is currently Professor of Medicine at Geisel School of Medicine and an attending physician in the ID Section at Dartmouth-Hitchcock Medical Center.  His research interests have included toxic shock syndrome and treatment of septic shock, and areas of special clinical interest include HIV infection, Lyme disease, and bone and joint infections.Underwriter: Mack Molding

This meditation is part of the Mindfulness Based Stress Reduction Program of the University of Massachusetts Worchester. Dr. Iris Stammberger has practiced mindfulness meditation for 20 years and is a teacher of Mindfulness-Based Stress Reduction at the Beth Israel Hospital and other venues. The Body Scan is a core component of her practice and teaching. Let this meditation bring about positive change in your life.

This is one of the formal practices of the Midnfulness Based Stress Reduction Program of the UMass Center for Mindfulness. Dr Iris Stammberger has practiced mindfulness meditation for 20 years and is a teacher of Mindfulness-Based Stress Reduction at the Beth Israel Hospital and other venues. The Body Scan is a core component of her practice and teaching. Let this meditation bring about positive change in your life.

Dr. Singleton is a board-certified anesthesiologist and past president of the Association of American Physicians and Surgeons. She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at University of California at San Francisco Medical Center, then her Anesthesia residency at Harvard's Beth Israel Hospital. She was on the faculty at Johns Hopkins Hospital in Baltimore, Maryland before returning to California for private practice at Cedars-Sinai Medical Center in Los Angeles and Alta Bates Medical Center in Berkeley. While still working in the operating room, she attended UC Berkeley Law School. She interned at the National Health Law Project, and practiced insurance and health law. Along with delivering medical and educational supplies, she started two make-shift medical clinics in two rural villages in El Salvador.   Website: marilynsingletonmdjd.com; Twitter: @MSingletonMDJD.  

Dr. Marilyn Singleton discusses how to identify elder abuse in nursing homes. Dr. Singleton is a board-certified anesthesiologist and past president of the Association of American Physicians and Surgeons. She graduated from Stanford, earning her MD at UCSF, completed 2 years of Surgery residency at UCSF, and then her Anesthesia residency at Harvard’s Beth Israel Hospital. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional law and administrative law. She interned at the National Health Law Project and practiced insurance and health law. She teaches classes in the recognition of elder abuse and constitutional law for non-lawyers. Marilyn Singleton MD Website - https://marilynsingletonmdjd.com/ Follow Dr. Singleton on Twitter - https://twitter.com/MSingletonMDJD   

Dr. Danny Sands is passionate about healthcare transformation. A practicing physician with training and experience in clinical informatics, Dr. Sands has worked in a variety of capacities in the healthcare IT industry for over 25 years. He spent almost 14 years doing clinical informatics at Beth Israel Deaconess Medical Center, where he developed and implemented innovative systems to improve clinical care delivery and patient engagement, including clinical decision support systems, an EHR, and one of the nation's first patient portals. This was followed by leadership positions including Cisco, Zix Corporation, and others. Dr. Sands is the recipient of numerous healthcare honors, including recognition in 2009 by HealthLeaders Magazine as one of “20 People Who Make Healthcare Better.” He is the co-author, with e-Patient Dave deBronkart, of Let Patients Help. Dr. Sands has earned degrees from Brown University, Ohio State University, Harvard School of Public Health, and trained at Boston City Hospital and Boston's Beth Israel Hospital. Dr. Sands holds an academic appointment at Harvard Medical School and maintains a primary care practice at Beth Israel Deaconess Medical Center in which he makes extensive use of health IT—much of which he helped to introduce. In addition to practicing, Dr. Sands works with a number of innovative companies and is a co-founder and the chief advocacy officer of the Society for Participatory Medicine. He is a popular speaker and consultant, blogs at DrDannySands.com and tweets as @DrDannySands.

Dr. Augustus A. White, Orthopaedic Surgeon-in-Chief at Beth Israel Hospital in Boston for thirteen years, Ellen and Melvin Gordon Distinguished Professor of Medical Education, Professor of Orthopaedic Surgery at Harvard Medical School (HMS) and Professor Emeritus of the Harvard/MIT Division of Health Sciences and Technology. Dr. White served our country as Vietnam combat surgeon in the Army Medical Corps and was awarded the Bronze Star. An inspiring life story as we journey with him in the segregated South as a Memphis youth, that would culminate in a career that would position him as an internationally known, widely published authority on biomechanics of the spine, fracture healing, surgical and non-surgical care of the spine. Author of "Seeing Patients": https://www.amazon.com/Seeing-Patients-Surgeons-Medical-Preface/dp/0674241371/ref=sr_1_1?crid=11KG1VW5WSSNI&dchild=1&keywords=seeing+patients+augustus+white&qid=1615172018&sprefix=seeing+patients%2Caps%2C234&sr=8-1Author of "Overcoming": https://www.amazon.com/Overcoming-Lessons-Triumphing-Adversity-Humanity/dp/1642935484/ref=sr_1_1?dchild=1&keywords=overcoming+augustus+white&qid=1615172095&sr=8-1Dr. Wayne Southwick: https://www.legacy.com/obituaries/nhregister/obituary.aspx?n=wayne-o-southwick&pid=179643343&fhid=13044Dr. Tom Catena: https://theheartofnuba.com/meet-tom-catena/We continue our "Special Agent" series looking at the OODA as framework for relationships all around us. The first casualty of familiarity is active observation!Support the show (https://www.venmo.com/DeviceNation)

For Your Health! No, really. Dr. Marilyn Singleton joins us this week to discuss, from a clinical perspective, Coronavirus and all the ways to healthily address the pandemic.  Dr. Singleton is a board-certified anesthesiologist and immediate past president of the Association of American Physicians and Surgeons. She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at University of California at San Francisco Medical Center, and her Anesthesia residency at Harvard's Beth Israel Hospital.      She was on the faculty at Johns Hopkins Hospital in Baltimore, Maryland before returning to California for private practice at Cedars-Sinai Medical Center in Los Angeles and Alta Bates Medical Center in Berkeley. While still working in the operating room, she attended UC Berkeley Law School focusing on constitutional and administrative law.      She interned at the National Health Law Project, and practiced insurance and health law. Dr. Singleton has published numerous articles, given presentations on health policy, and had many radio and television appearances. She started a blood pressure screening clinic at her church and make-shift clinics in two rural villages in El Salvador. Dr. Singleton ran for Congress in 2012.Make sure you connect with our sponsor Kim Yeater, and tap in to her free coaching session at:Calendly.com/kimyeater

Gregory Wrightstone is a geologist with more than 35 years spent investigating the Earth and its processes. He earned an undergraduate degree from Waynesburg University and a masters degree in geology from West Virginia University. He is also the author of a new book -- Inconveninet Facts: The science that Al Gore doesn't want you to know. TOPIC: Renewables are reliably unreliable. Germany and Texas are finding that out!! Tim Bryce is is a freelance writer residing in the Tampa Bay area of Florida. An avid writer and speaker discussing everything from business and management, to politics and morality, to systems and technology in our ever changing world. In addition to his columns and blog entitled "The Bryce is Right' which is read by thousands of people worldwide. Tim has also been published in a wide range of publication from the WASHINGTON TIMES to the HUFFINGTON POST.. Tim’s new book, “ “Before You Vote: Know How Your Government Works”, What American youth should know about government" TOPIC: OBIDEN'S POLITICALLY CORRECT CABINET!! Dr. Marilyn Singleton is a board-certified anesthesiologist. She is President of the Association of American Physicians and Surgeons (AAPS). She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at UCSF, then her Anesthesia residency at Harvard’s Beth Israel Hospital. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional law and administrative law. She interned at the National Health Law Project and practiced insurance and health law. She teaches classes in the recognition of elder abuse and constitutional law for non-lawyers. TOPIC: Using COVID Fear to Divide and Rule!!

Dr Iris Stammberger has practiced mindfulness meditation for 20 years and is a teacher of Mindfulness-Based Stress Reduction at the Beth Israel Hospital and other venues. The Body Scan is a core component of her practice and teaching. Let this meditation bring about positive change in your life.

Dr. Ron Ruden, presented by Kath Temple       Dr. Ron Ruden is a groundbreaking innovative New York doctor and author who created Havening Techniques – changing the brain with Neuroscience. Dr. Ron received his Ph.D. in organic chemistry from Northwestern University in 1971 at the age of 24. He was then offered a post-doctoral fellowship at Harvard with Nobel Laureate E.J. Corey. After his training with Professor Corey, he obtained an assistant professorship at age 26 which allowed him to open his own research lab at Rutgers University. He then attended Medical School at Mount Sinai, graduating in 1979. After an internship and residency at Beth Israel Hospital in New York, he accepted a fellowship in clinical nutrition at Memorial Sloan Kettering Cancer Center in New York where he stayed on and helped run the department.In 1983, he opened a medical practice. From the beginning he has funded research using neuroscience to help solve some complex medical problems. In 1997, he published a book called The Craving Brain which dealt with addictive behaviour. In early 2000, he was introduced to a method called ‘Tapping', which led to his discoveries involving the clinical application of brain waves and the publication in 2010 of his second book When the Past is Always Present. The applications he developed became known as Havening Techniques.Havening is Amygdala Depotentiation Therapy. It is gentle, and highly effective in removing trauma. Dr Ron, and his twin brother, Dr Steven Ruden have trained Practitioners all over the world. Their great legacy is healing the world through all the Practitioners they and their team of Trainers have trained.

Nada Khogali was born in a very rural village in Sudan. Her family migrated to the United States very early on in her life pursuing educational success. She grew up in Lansing, Michigan, and attended public schools. While trying to find her way, she owned a local bakery and was a medical technologist. She finally found her lifelong calling and attended medical school at Michigan State University and completed residency at the University of Michigan Emergency Medicine program.  Dr. Khogali continues to practice medicine.  She is also the co-founder of Teenunme an educational platform for high school students. The platform guides high school students to be their most competitive and get into the college of their dreams. Dr. Monique McCray is an American emergency medicine consultant at the Cleveland Clinic in Abu Dhabi (CCAD).   She is also the CEO of Teen UN Me, a mentoring service that guides students to become their most competitive for university and scholarship applications.    Dr. McCray moved to Abu Dhabi in 2014 to set up and opened the CCAD emergency department.   She was a key leader in the development and implementation of the current policies and procedures that make the CCAD emergency department one of the best in the region. She holds a bachelor’s of Chemistry from Bennett College for Women in Greensboro, North Carolina and she was a scholar at Reading University and Oxford University in England during her undergraduate years.  She completed a Masters in Anthropology at The Ohio State University before going to medical school at the University of Colorado Health Science Center.  Post medical school, she trained at National Naval Medical Center in Bethesda, MD before serving as a flight surgeon in the US Navy.  Dr. McCray returned to training, after military service, and completed an emergency medicine residency at Newark, Beth Israel Hospital. Most recently, she completed the Harvard University Managing Health Care Delivery executive certificate course.
 Previous to her current position in Abu Dhabi, Dr. McCray practiced in Washington DC in the Ascension and Kaiser Permanente health care systems.   She consulted with Sheraton Healthcare corporation in 2014 instituting corrective metrics and systems into problematic emergency departments.   Her research interest is in health literacy and its impact on developing populations and countries in the Gulf region.  While at CCAD she has also developed innovative methods for early detection of septic patients in the emergency department and she has spearheaded the extended use of hospital technology for patient education and health literacy in the emergency department. https://www.teenunme.com/ Reach out to Drs. Khogali and McCray for your teen's complementary training at info@teenunme.com as a thank you for listening. Be sure to mention that you heard about Teen UN Me from the Fearless Freedom with Dr. G podcast _______________________________________________________________ Que the music! Drum roll, please! This is episode 100!!!! 100 times we have gathered together to face fear and emerge victoriously 100 times you have participated in our awesome Fearless Freedom Tribe 100 times and opportunities for me to say thank you and express my gratitude to you for joining me on this journey to your greatness 100 times you contributed to the show the 17000 downloads milestone and nearing the corner to 18000 downloads!!!!! Thank you for your help in making this podcast a success!!! [Insert happy dance emoji] Thank you so much for subscribing to the podcast, listening to the podcast, sharing with a friend or two, and leaving a 5-star rating.    ______________________________________________   SWAG! SWAG! SWAG! I am also looking for feedback on what kind of swag I should get for the podcast. What would you like to have in our tribe’s swag store? So far, I have tech swag like blue blockers, jump drives, earphones, masks, stickers, water bottles.  Thanks in advance for your great ideas! ______________________________________________ Podcasts from the Podcasting Launch Course are starting to come out! The amazing women in the course have created incredible content and shows that are pure fire! Check out the three shows that are currently out. Show them some love by subscribing, leaving a 5-star rating, sharing, and leaving a positive comment.    Pivot & Bloom Podcast  https://bit.ly/PivotandBloom   The Drama-Free Workplace with Patti Perez  https://bit.ly/DramaFreeWorkplace   Living at Your Finest  https://www.buzzsprout.com/1202669   _____________________________________________ Looking to start a podcast? Now is a great time to do just that! Begin by learning more about podcasting and getting started.  You can join the Podcasting Launch Course for Professionals to work with me to get your podcast out on the airwaves.  Yes, that’s right, the Podcasting Launch Course for Professionals is open to enrollment and ready for you.   https://charmainegregorymd.com/step/podcasting-launch-masterclass/ Are you too busy to participate in a facilitated course but still want to get your show started? The Podcast in a Box is for you! You provide the audio for your first 5 five shows to launch with a bang, we do the REST.  https://bit.ly/DFYpodcast Get off the fear fence today. Your tribe is waiting to hear your voice! ______________________________________________

This week IAQradio+ looks to the left coast for a conservative’s perspective on the COVID19 pandemic and will interview Marilyn Singleton, MD, JD , a California physician who also holds a law degree.  Dr. Singleton will talk about the intersection of public health, medicine, law and public policy. The response to a public health crisis can be improved with transparent fact-based communication from government agencies and experts in the field. That conversation should include a variety of opinions in establishing consensus for public policy that serves the need to protect public health while maintaining the civil liberties afforded under the constitution and jurisdictional law. IAQradio+ prides itself in being the leading forum in providing a science-based approach from research  to practice with a focus on show content related to diagnosing and responding to IAQ issues and remediation protocols.  So please join Radio Joe, the Z-man and this week’s guest for a live interview exploring the  issues surrounding the pandemic from a unique California perspective! Marilyn M. Singleton, M.D., J.D. Dr. Singleton is a board-certified anesthesiologist. She is past president of the Association of American Physicians and Surgeons (AAPS). She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at UCSF, then her Anesthesia residency at Harvard’s Beth Israel Hospital. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional law and administrative law. She interned at the National Health Law Project and practiced insurance and health law. She teaches classes in the recognition of elder abuse and constitutional law for non-lawyers. Marilyn comes from a long line of trailblazers.  Her grandfather graduated from Ohio State medical school in 1905.  He served the public in Lima, Ohio by taking care of the black population and was active in politics and his community. Marilyn’s father who was from Virginia, was a flight surgeon at the Tuskegee Army-Air Corps base.  Her mother instilled the spirit of volunteerism – whether the Red Cross or the Urban League.  When Marilyn was in high school, her mother began her career as a social worker. For more information on this week’s guest: https://marilynsingletonmdjd.com/about/ For more information on AAPS: https://aapsonline.org/

Dr Marilyn Singleton, the past president of the American Association of Physicians and Surgeons discusses the difference between the Affordable Care Act, better known as ObamaCare and President Trump’s health care plan. She further details the effects that each will have from the costs of and whether such increases access to the American healthcare system. Despite being told, “they don’t take Negroes at Stanford”, Dr. Marilyn Singleton graduated from Stanford and earned her MD at UCSF Medical School. She then completed two years of surgery residency at UCSF, followed by an anesthesia residency at Harvard’s Beth Israel Hospital. Dr. Singleton is a board-certified anesthesiologist. She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at UCSF, then her Anesthesia residency at Harvard’s Beth Israel Hospital. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional law and administrative law. She interned at the National Health Law Project and practiced insurance and health law. She teaches classes in the recognition of elder abuse and constitutional law for non-lawyers. Dr. Singleton ran for Congress in California’s 13th Congressional District in 2012, fighting to give its 700,000 citizens the right to control their own lives. Dr. Singleton's Bio - www.theconservativepundit.net/meet-the-pundits/dr-marilyn-m-singleton-md-jd/ Assoc of American Physicians And Surgeons - http://www.aapsonline.org/ This journey through Life - https://thisjourneythroughlife.com/dr-singleton/ Dr Singleton's Blog - https://marilynsingletonmdjd.com  

Welcome to episode #105, Season 4 of Creating a New Healthcare. Today we welcome one of the most prolific and influential healthcare policy experts of our era. Professor Ezekial Emanuel is the Vice Provost for Global Initiatives and Co-Director of the Healthcare Transformation Institute at the University of Pennsylvania. He is also a Special Advisor to the Director General of the World Health Organization. Dr. Emanuel was the founding chair of the Department of Bioethics at the National Institutes of Health. From January 2009 to January 2011 he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget, and the National Economic Council. He is also a breast oncologist, having earned his MD at Harvard Medical School, completed a residency in Internal Medicine at the Beth Israel Hospital in Boston, and then completed an oncology fellowship at the Dana Farber Cancer Institute, where he was also appointed as faculty. Dr. Emanuel has written and edited 14 books and over 300 articles, and is the world’s most cited bioethicist. He is a frequent contributor to the Atlantic, the New York Times, the Wall Street Journal, and the Washington Post, and regularly appears on television and radio.In this episode, we’ll touch on the following:The fragility of the US employer-based healthcare payment system and how the COVID-19 pandemic is nudging us to a universal payment system.The differences between a universal payment program and a single payer system.An illustration of a capitated primary care trial demonstrating the advantages to providers and patients.What the US can learn from other advanced nations in terms of primary care access and healthcare payment reform.The multi-pronged solutions that Dr. Emanuel recommends to address the insidious institutional racism and the inequities that are embedded in US healthcare deliveryI believe it was H.L. Mencken who said that there are often simple solutions to complex problems, and those simple solutions are typically wrong. Dr. Emanuel does not offer simple solutions to the complex problems in our healthcare system. Instead, he offers thoughtful, studied, and ethical solutions that directly and realistically address the fundamental flaws in our healthcare system. These are serious flaws that leave tens of millions of Americans with no or sub-optimal health insurance, limit access to preventive primary and specialty healthcare for tens of millions of Americans, and create perverse and unethical incentives for providers and health systems that greatly inhibit them from delivering the type of healthcare they would like to offer.Dr. Emanuel is one of the most cited healthcare policy scholars and advisors of our era, as well as one of the most prolific researchers and authors. He is one of the finest healthcare educators and thought-leaders our country has ever produced. It is well worth our time to listen to and study the critically important lessons he is teaching us.Until next time,Be safe and be well.Zeev Neuwirth, MD 

This week’s episode of Circulation on the Run features author Robert Yeh and Associate Editor Brendan Everett as they discuss the article "Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings from the EXTEND Study." TRANSCRIPT Carolyn Lam: Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr Carolyn Lam, Associate Editor from the National Heart Center and Duke National University of Singapore. Greg Hundley: And I'm Greg Hundley, Associate Editor, Director of the Pauley Heart Center at VCU Health in Richmond, Virginia. Well, Carolyn this week, we're going to examine outcomes in patients that have undergone transcatheter aortic valve replacement or TAVR. I can't wait to get to the results from the EXTEND study. But before we do that, how about we grab a cup of coffee and start in with some of the papers and maybe I'll go first this time. My paper involves a validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. And the corresponding author is Dr Seema Mital from the Hospital for Sick Children. Well, Carolyn in this study, the objective was to develop and validate a sudden cardiac death risk prediction model in pediatric hypertrophic cardiomyopathy to guide sudden cardiac death prevention strategies. To address this, the authors performed an international multi-center observational cohort analysis. Phenotype positive patients with isolated hypertrophic cardiomyopathy, who were under the age of 18 years at diagnosis were eligible. The primary outcome variable was the time from diagnosis to a composite of sudden cardiac death events at five years of follow-up. That included sudden cardiac death, resuscitated sudden cardiac arrest, and aborted sudden cardiac death, that is, an appropriate shock following primary prevention ICD. Carolyn Lam: Nice. What did they find? Greg Hundley:   Well, overall 572 patients met the eligibility criteria with 2,855 patient years of follow-up. The five-year cumulative proportion of sudden cardiac death events was 9%. Risk predictors included age at diagnosis, documented non-sustained ventricular tachycardia, unexplained syncope, septal diameter Z scores, LV posterior wall diameter Z scores, LA diameter Z scores, peak LV outflow tract gradients, and the presence of a pathogenic variant. Now, unlike adults, LV outflow tract gradient had an inverse association and family history of sudden cardiac death had no association with sudden cardiac death. The combination of clinical and genetic data were developed to predict five-year freedom from sudden cardiac death. In conclusion, the authors study provides a validated sudden cardiac death risk prediction model with over 70% prediction accuracy and incorporates risk factors that are unique to pediatric hypertrophic cardiomyopathy. These results therefore raise the possibility that an individualized risk prediction model has the potential to improve the application of clinical practice guidelines and shared decision making for these children prior to an ICD insertion. Carolyn Lam: Very interesting. Well, Greg, have you ever wondered what are the temporal trends in the burden of comorbidities and risk of mortality among patients with heart failure with preserved ejection fraction or HFpEF and heart failure with reduced ejection fraction or HFrEF? Well, the next paper comes from Dr Caughey and colleagues from University of North Carolina and North Carolina State University who performed an analysis of the community surveillance component of the atherosclerosis risk in communities, or ARIC study, and they found a significant increase in the burden of comorbidities among hospitalized patients with HFpEF as well as HFrEF across both sexes. Higher number of comorbidities was associated with higher risk of one-year mortality with a stronger association noted among patients with HFpEF compared to HFrEF. The one-year mortality risk associated with increasing comorbidity burden also increased over time. Greg Hundley: Interesting, Carolyn. So more comorbidities in HFpEF versus HFrEF. How do we use this clinically? Carolyn Lam: This study demonstrated a shift from ischemic etiology heart failure to multi morbidity heart failure over time, particularly among patients with HFpEF. This really highlights the importance of a holistic approach in targeting multimorbidity burden and guiding the management of patients with heart failure. Greg Hundley: Very interesting. Well, Carolyn, my next paper comes from Professor Matthias Nahrendorf from Mass General Hospital and involves the relationship between bone marrow endothelial cells and myelopoiesis in those with diabetes.  Carolyn, this study investigated the role of bone marrow endothelial cells in diabetic regulation of inflammatory myeloid cell production. The authors utilized three types of mice with diabetes, including a streptozotocin model, a high fat diet model, and a genetic induction using leptin receptor deficient mice. They assayed leukocytes, hematopoietic stem cell and progenitor cells, and endothelial cells in the bone marrow with flow cytometry and expression profiling. Carolyn Lam:  What did they find? Greg Hundley:   Well in diabetes, they observed enhanced proliferation of hematopoietic stem cells leading to augmented circulating myeloid cell numbers. Analysis of bone marrow niche cells revealed that endothelial cells in diabetic mice expressed less CXCL-12, a retention factor promoting hematopoietic stem and progenitor cell quiescence. Transcriptome wide analysis of bone marrow endothelial cells demonstrated enrichment of genes involved in epithelial growth factor receptor signaling in mice with diet induced diabetes. In summary, Carolyn, in diabetes, bone marrow endothelial cells participate in the dysregulation of bone marrow haematopoiesis specifically diabetes reduces endothelial production of CXCL-12, a quiescence promoting niche factor that reduces stem cell proliferation. The authors also describe a previously unknown counterregulatory pathway in which protective endothelial EGFR signaling curbs hematopoietic stem cell and progenitor cell proliferation as well as myeloid cell production. Carolyn Lam:     Wow, thanks for explaining all of that, Greg. For this next paper, we're going to switch tracks a little. This comes from Dr Drakos and colleagues from University of Utah in Salt Lake City. They noted that significant improvements in myocardial structure and function have been reported in some advanced heart failure patients. This is they're going to call responders and the responders improve the myocardial structure and function following left ventricular assist device induced mechanical unloading. This therapeutic strategy may alter myocardial energy metabolism in a manner that reverses the deleterious metabolic adaptations of the failing heart. Dr Drakos and colleagues hypothesized that the accumulated glycolytic intermediates are channeled into cardioprotective and repair pathways, which may mediate myocardial recovery in these responders. To test this hypothesis, they prospectively obtained paired left ventricular atypical myocardial tissue from non-failing donor hearts, as well as responders and non-responders at left ventricular assist device implant and at transplantation. They conducted protein expression and metabolic profiling and evaluated mitochondrial structure using electron microscopy. Greg Hundley:   Interesting. What did they find, Carolyn? Carolyn Lam:     The recovering heart appears to direct glycolytic metabolites into pentose phosphate pathway and one carbon metabolism, which could contribute to cardioprotection by generating NADPH to enhance biosynthesis and by reducing oxidative stress. This new information could redirect future translational investigations to efforts to identify novel therapeutic targets for myocardial recovery in patients with chronic heart failure. Well, Greg, can I tell you a little bit more about what else is in this issue? There's a letter by Dr Wang regarding the article, A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction, and there's also a response by Dr Yan. In Cardiovascular Case Series, there's a paper by Dr Michelena on the nosology spectrum of the bicuspid aortic valve condition, the complex presentation of valvular aortopathy. That's so interesting. There's a research letter by Dr Gaudino on the response of cardiac surgery units to COVID-19, an internationally based quantitative survey. As well as another research letter by Dr Salem on cardiovascular toxicities associated with Hydroxychloroquine and azithromycin and analysis of the World Health Organization pharmacovigilance database. There is a perspective piece by Dr Jacobs entitled The Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA's Mission: Lifeline. In cardiology news, Tracy Hampton reviews three papers, one, Video-Based AI for Beat-to-Beat Assessment of Cardiac Function in Nature, 2020. Two, Dynamic Transcriptional Responses to Injury of Regenerative and Non-regenerative Cardiomyocytes Revealed by single Nucleus RNA Sequencing, that is in developmental cell 2020. And three, ATP and Voltage-Dependent Electro-Metabolic Signaling Regulates Blood Flow in the Heart, the proceedings of the National Academy of Science, 2020. Greg Hundley:   Very nice. Well, I've got an in-depth review from Dr Bin Zhou regarding the heart regeneration by endogenous stem cells and cardiomyocyte proliferation, controversy, fallacy, and progress. And then there are three on my mind pieces. The first is from Dr Rashmee Shah regarding machine learning and artificial intelligence. Do we need more data, or do we need the right data? The next one is from Sharon Reimold and it discusses the importance of gathering historical information on risk factors when seeing patients with, or suspected, of COVID-19. And then finally, Dr Prateeti discusses ethical challenges in cardiology during the COVID-19 pandemic. Well, Carolyn, what a great review. How about we proceed to that feature discussion? Carolyn Lam: Let's go. Greg Hundley: Well listeners, we are now turning to our feature discussion and this week we have Dr Robert Yeh, also Bobby Yeh, from Beth Israel Hospital and our own associate editor, Dr Brendan Everett from Brigham and Women's Hospital. Welcome gentlemen. Bobby let's start with you. Can you tell us a little bit about some of the background related to your study, and then what hypothesis were you trying to address? Robert Yeh: The study that we performed is the sub study of what we're calling the EXTEND study, which is an NIH funded group of investigations meant to really examine what the value is of real world data and how it can augment clinical trial evaluations of medical devices and therapies. We know that randomized clinical trials remain the gold standard for therapeutic evaluation, but they are expensive, difficult to do, and sometimes impractical. Real world data is cheaper, it's potentially more efficient to do observational research studies, and in fact the 21st Century Cures Act explicitly asks, among other things, that the FDA explore the use of real-world data for regulatory evaluations. People have problems with real world data, of course, they have their own inherent challenges which are subject really to confounding. What we thought about is, well, there's probably this middle ground that we and others have proposed, which is can't real world data somehow supplement or augment randomized clinical evaluations, and in particular, in our question, can real world data be the provider of outcomes in place of adjudicated clinical trial outcomes? What we did is we took two large pivotal randomized clinical trials of transcatheter aortic valve replacement, namely the CoreValve, high risk, and intermediate risk trials. Otherwise, the intermediate risk trials known as the SURTAVI trial. And we found those patients in those trials and then linked them with real world data from administrative claims databases in Medicare. Our hypothesis was that had the trial been evaluated in terms of outcomes by the Medicare claims instead of the clinical trial adjudicated outcomes. Our main question was, would we have had the same findings within those trials? Would the primary hypothesis of those trials still have been met with this alternative clinical trial end point ascertainment strategy? Greg Hundley: In your study design, how did you accomplish the comparisons? You've told us a lot about the study population. Was this everyone from those two studies or was this a subgroup of them? Maybe just expand on that a little bit. Robert Yeh: Good question. This is a US based comparison, so we have claims for US patients, and most patients in these trials were in the United States, but the CoreValve trial and the SURTAVI trials, we took all of this patients and then tried to find those patients who we could also find in Medicare claims. It turns out that in order to qualify for Medicare, you have to be over 65 years of age, under most circumstances. And so it's limited to really those patients over age 65, who we could then search for in Medicare and then within Medicare, there's two types of insurance, fee for service and Medicare Advantage managed care. And what we can only find are those patients who are in Medicare fee for service, which represents somewhere between two thirds and three quarters of patients age greater than 65 or older. So it is a subgroup of patients in these two large pivotal randomized trials. We've compared those who could not be linked versus those who could, find large part, from some of the age differences, which are just inherent in looking at Medicare, there are really not that many differences between those two groups. Greg Hundley: Bobby, what did you find? Robert Yeh: We found those patients. So now we have this situation where we have patients in trials, and we can look at them from two lenses. The same group of patients, one lens is through the clinical trial lens and the second is through the lens of real-world data, those exact same patients. We found that whether or not we ascertained their outcomes via claims or with clinical trial adjudication, essentially the primary hypotheses were identical, that in both scenarios, the transcatheter aortic valve was non-inferior to the traditional surgical aortic valve replacement, that the effect sizes and the hazard ratios, the confidence intervals, they were roughly the same. In fact, for the primary endpoint of the high-risk pivotal study, which was all cause mortality, it was identical. It turns out that Medicare claims and what we called the denominator file very accurately identifies exactly when a patient dies. It does so equally well compared to rigorous clinical trial adjudication. For SURTAVI the primary endpoint was combined death or stroke in that case, stroke is reasonably accurate. There were a lot of deaths that also drove that combined end point. And the net result was that really very similar, both effect sizes and primary, P values for those comparisons. Greg Hundley: Now how about secondary analysis? Robert Yeh: I think the secondary analysis that's where you had some variability. There are some types of outcomes in this device specific trial that are procedure oriented. Pacemakers are a concern. Aortic valve reintervention is a concern. Those end points in billing claims turns out are quite accurate. You can understand why. I think providers and institutions, when they do a service that requires insertion of a new device, they want to get paid for those devices and they do that billing accurately.  But there are other claims which I think are a little bit more subjective, diagnoses that are more subjective, those like bleeding or cardiogenic shock, those things actually started to look different. And in fact, in some cases started to give you different inferences if you used the clinical trial data versus the real-world data. And so if I were to summarize it, I would say that mortality looked absolutely pristine identical between the two groups that some diagnoses, particularly procedural ones, looked quite good, sufficient, I think, for an accurate estimation of the treatment effect size as well as the magnitude of the risk, but then some end points, I think the softer more subjective endpoints are slightly different. Greg Hundley:   Thank you so much, Bobby. Now we're going to turn to our associate editor, Dr Brendan Everett, who has helped work this article through the entire editorial process and is also an expert epidemiologist. Brendan, we have randomized trial data versus real world data. How do you interpret these results in the context of how we're conducting studies both now and then how we will conduct them in the future? Brendan Everett: If you think of observational research and clinical research on a spectrum with truly just observational studies on one end, where you were trying to look at an exposure and an outcome and adjusting for potential confounders, to tightly controlled randomized trials on the other, Bobby's group has managed to create a hybrid, which I think gives us some opportunity to not have to be either on one and or the other of the spectrum. What I mean by that is that there are a couple key features of trials that are retained in the approach that Bobby used, and his group used. He mentioned those, but I want to emphasize them. I think the key thing is that there's a randomization step. From the perspective of an epidemiologist, that's key because it balances between the people who get your therapy, in this case a TAVR and don't get the new therapy…confounders that you can measure and confounders that you can't measure, the unmeasured confounders. So it allows some balance between the two treatment groups so that you can be sure, at least at baseline, that they're similar groups and what you're measuring after that point is the effect of the intervention. The key piece that Bobby replaced is the classical trial ascertained end points where investigators are asked if their patient had one of these outcomes such as a stroke or a death, and then they're adjudicated independently. As he pointed out, I think there are many of those outcomes, at least in this particular application, are really well collected by billing data. And in fact, some might argue that in some cases they're actually better collected. There's a higher sensitivity, if a somewhat lower specificity for the events of interest. I think the key question, and you touched on this, Greg, is what about the outcomes that maybe are not collected quite as well by billing data? In particular, remember that any clinical trial is looking at both the efficacy of a novel treatment as well as its safety. You ultimately, at the end of the trial, want to be able to compare efficacy with safety, to make a decision, in this case from the FDA, a regulatory decision about whether to approve the device or the drug. The question becomes, what safety events are you worried about and how reliably are you going to be able to collect them with claims data? In this case, I think Bobby mentioned that the bleeding data maybe was not quite as good as some of the other safety concerns that are common in TAVR. I think when you look to apply this approach, which I think is ingenious, to a different research question, you have to ask whether or not the end points, the efficacy end points, and the safety end points that you're collecting will be done in a valid and consistent and sensitive way with claims data as compared with the traditional trial ascertainment process. In this case, I think they were, but that's not always the case. We can all think of examples where you might run into some trouble depending upon what your end points are. Greg Hundley:   Well, gentlemen, this has been really an informative study to present and talk about in this feature discussion. I want to ask you both just briefly, in a minute or so, what do you see as the next step forward in research in this particular area? Maybe Bobby you first and then we'll follow with Brendan. Robert Yeh:  I think that there are a couple of different areas that really need to be pushed forward. One, and Brendan alluded to this, is because these studies are really domain specific this validation does not tell us that all claims can be used to answer all questions, that in this particular question it worked, but in others it might not, so more validation work in different fields, different randomized trials, need to be done. We're doing some of those, but they need to be done throughout so we can really get a better sense of what are the types of questions that are best answered by this type of linkage approach. The second that is more operational, we were limited to Medicare claims data, so for questions for patients who are younger than 65, this approach just doesn't work. Whereas a place like Sweden can do a large national registry like they did in the TASTE randomized clinical trial and do this for their entire country. We do need to develop better systems that have comprehensive real-world data collection. Maybe those involve more consolidated electronic health system, health record data that are available in big integrated health systems, for example, but a better system needs to be developed that can answer questions among more than just Medicare fee for service patients. Greg Hundley:   Very good. And Brendan? Brendan Everett: Well, I think it's a really promising approach to trying to lower the cost of clinical trials and to do valid research on the effect of some treatments as compared to others. From my standpoint, we have to be careful that we don't try and shortcut the process too much. In particular, I think the randomization step, at least for novel treatments, is of fundamental importance. And of course, to do that, you have to collect a population that is then willing to be randomized to option A or B. There's a lot of upfront work that is not eliminated by looking solely at the outcomes, using this technique to look at the outcomes. There's a lot of upfront work to collect the patients and then randomize them. I think also it's important, as we saw recently, that the quality and validity of the database be ascertained and be well-established both with the investigators and the providers of the database. We can see that sometimes, if you're not careful, you can come up with outcomes that are not correct because of the example. Of course, I'm alluding to is the two papers in Lancet and the New England Journal that had to be retracted that were large database studies as well. The quality of the underlying data remains paramount. That, of course, is where a lot of the elbow grease comes in. It's not just in the ascertainment of the events, but a lot of the stuff that leads up to counting the events at the end of the study. Greg Hundley:   Well, listeners, this has been just a superb discussion. On behalf of Carolyn and myself, we wish you another great week and look forward to catching you on the run next week. Take care.  This program is copyright, the American Heart Association 2020.  

Herd mentality that has developed over the past few months has dissolved our nation; The truth about Robert E. Lee and Abraham Lincoln; Hospitals falsely labeling deaths to alter data on Covid death rates; Business bailouts, more information coming out; Pelosi gets upset when someone asks her if she would release her tax information; People writing Black Lives Matter on public roads; Savage a self-made man, no white privilege played a part in his success; NYC Mayor Bill de Blasio trolls Trump painting BLM on 5th Avenue; Pelosi talks about statues, has no pride in them; Savage movie watching; Savage is not a cheerleader. In an interview from Aug. 29, 2019, Dr. Marilyn M. Singleton joins to talk Russia, Racists, and Ridiculousness … an interview Savage enjoys very much. Dr. Singleton is a board-certified anesthesiologist. She is President of the Association of American Physicians and Surgeons (AAPS). She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at UCSF, then her Anesthesia residency at Harvard’s Beth Israel Hospital. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional law and administrative law. Learn more about your ad choices. Visit megaphone.fm/adchoices

  Hydroxychloroquine is an old medicine and treatment for conditions causing cyclical fevers like malaria. But hydroxychloroquine has been used in the treatment of infections like SARS, influenza and others. Why did this happen? Where did it start? And what is its place today in the treatment regimen for COVID-19? My guest today is Dr. Adam Rodman of Bedside Rounds Podcast. He is an internist and amateur medical historian who has studied in depth on the origins of quinine, chloroquine, and hydroxychloroquine. He also had a frantic month of treating COVID-19 in his Boston, MA hospital where he watched first hand the dangers of COVID and the effectiveness of their treatment regimens. By looking at the past flu pandemic in 1918 he offers some great insight into how people haven't changed a whole lot in their reactions to wearing masks, social media, and the like. Listen in as we take a trip into the past and try to understand the present and perhaps predict the future of this current pandemic. Dr. Adam Rodman is an internist at Beth Israel Hospital in Boston, MA. He is also the host of the Bedside Rounds podcast. show notes Bedside Rounds Podcast: Bedside Rounds is a podcast that looks at the history of medicine in all sorts of eras. Also, if you are an internist you can get CME credit for listening to the shows. Adam Rodman on twitter: @AdamRodmanMD Episode 087: The deception on the Coronavirus from our leaders. Samaritans Health Sharing Ministry: This is the ministry we use. Feel free to mention my name if you sign up - not sure if that helps you or not. Top 20 Physicians Podcasts Made Simply Web Site Creations: This is the great, affordable website service that built my wife's podcast site. I cannot recommend this company more to someone looking for creating a website. Always Andy's Mom: Home of my wife, Marcy's, podcast for parents grieving or those looking to help them. YouTube for Paradocs: Here you can watch the video of my late son singing his solo on the Paradocs YouTube page. Patreon - Become a show supporter today and visit my Patreon page for extra bonus material. Every dollar raised goes towards the production and promotion of the show.    

Ezekiel J. Emanuel is Vice Provost for Global Initiatives and chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania. From January 2009 to January 2011, he served as special advisor for health policy to the director of the White House Office of Management and Budget. Since 1997 he was chair of the Department of Bioethics at The Clinical Center of the National Institutes of Health and a breast oncologist. Dr. Emanuel received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. After completing his internship and residency in internal medicine at Boston’s Beth Israel Hospital and his oncology fellowship at the Dana-Farber Cancer Institute, he joined the faculty at the Dana-Farber Cancer Institute. He has since been a visiting professor at the University of Pittsburgh School of Medicine, UCLA, the Brin Professor at Johns Hopkins Medical School, and the Kovitz Professor at Stanford Medical School and visiting professor at New York University Law School. Dr. Emanuel has written and edited 9 books and over 200 scientific articles. He is currently a columnist for the New York Times. Learn more about your ad choices. Visit megaphone.fm/adchoices

It was so nice catching up with Mike. Mike and I went to school at Springfield College at the same time and connected over weightlifting. Hes competed or trained in so many different ways. From power lifting, strongman, crossfit, jujitsu and the list goes on. He then spent time at Beth Israel Hospital and a Physiologist which he got to help all kinds of people and ages. From the day I met him. I could tell he was a very driven person that is always trying to get better each day. Today Mike is an Army Performance Coach where he truly gets to really put his passion to the test when it comes to impacting others peoples lives not only physically but mentally. He is someone that truly believes in being kind and puts everyone first. This is an amazing listen that really digs deep on the impact of your mindset and how much you are capable of it you allow yourself to tap into your true potential.

WBZ NewsRadio's Suzanne Sausville reports on a special Mother's Day delivery for more than 150 healthcare workers and new moms at Beth Israel Hospital in Boston.

WBZ NewsRadio's Suzanne Sausville reports on a special Mother's Day delivery for more than 150 healthcare workers and new moms at Beth Israel Hospital in Boston.

On April 5, 2020, as states and countries become deeply entrenched in open-ended lockdowns due to COVID-19, Glenn Campbell finds himself in an unexpected place: a cancer ward in Boston. After 13 days at Beth Israel Hospital, he is beginning treatment for a relapse of his lymphoma, with a good chance of recovery in about 4 months. In this personal episode, light on demography, Glenn describes his treatment plan and cancer history. He also provides some insight into how a big-city hospital is dealing with COVID-19. Is it pandemonium in the wards. Are the staff stressed beyond the breaking point? As far as Glenn can tell, the answer is no. The hospital continues to function pretty much as it normally has. The virus requires many change in procedure, but there is one compensation for the staff: No more annoying visitors. Glenn can be seen recording this podcast in the YouTube version, direct from his hospital bed. — Also see DemographicDoom.com — Instagram & Twitter: @DemographicDoom — See the video version of this episode for notes, comments & corrections: j.mp/dd_hospital [ep 37, 6 April 2020]

EPISODE 37 -  Poet and Didn’t Know ItGuest: Charif ShanahanIn this episode, published author and celebrated Poet Charif Shanahan helps us to demystify Poetry. Through his unique perspective and lens, he shares what it’s like to be a professor, a student, and a biracial gay man with a passion for the written word.Charif’s Mini Bio - Charif Shanahan is the author of Into Each Room We Enter Without Knowing. He is a Jones Lecturer in Poetry in the Creative Writing Program at Stanford University. Shanahan’s poems appear in numerous journals, including American Poetry Review, The New Republic, The New York Times Magazine, and more.Mentioned in PodcastBook by Charif Shanahan Into Each Room We Enter without Knowing: poemsThe poem read on today’s podcast: StoryOther Authors and Poets mentioned in Today's PodcastCave CanemToni MorrisonAlice WalkerMaya AngelouLawrence FerlinghettiWalt WhitmanWilliam ShakespeareBooks I Know Why The Caged Bird Sings, Maya AngelouGod Help The Child, Toni MorrisonThe Beat Poets and Beat Poetry ContributionThe Beat Generation was a literary movement started by a group of authors whose work explored and influenced American culture and politics in the post-war era. ... Both Howl and Naked Lunch were the focus of obscenity trials that ultimately helped to liberalize publishing in the United States. Linda GreggLinda Gregg was mentioned in the podcast as being one of Charif’s major mentors. Her published books include Things and Flesh, Chosen By The Lion, The Sacraments of Desire, Alma, Too Bright to See, In the Middle Distance, and All of it Singing. Her poems also appeared in numerous literary magazines, inOn March 20, 2019, she died of cancer at the Beth Israel Hospital in New York City. WikipediaYusef KomunyakaaYusef is an American poet who teaches at New York University and is a member of the Fellowship of Southern Writers. Komunyakaa is a recipient of the 1994 Kingsley Tufts Poetry Award, for Neon Vernacular and the 1994 Pulitzer Prize for Poetry. He also received the Ruth Lilly Poetry Prize. WikipediaMusic: Madonna - Like A PrayerReach out to us here…WebsiteInstagramFacebookTwitterEmailYou can reach Sergio Novoa personally on InstagramTwitterFacebookVanessa WilkinsFacebookIGTheme song by:  http://djolgat.net

Bio: Dr. Singleton is a board-certified anesthesiologist. She is the immediate past President of the Association of American Physicians and Surgeons (AAPS). She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at UCSF, then her Anesthesia residency at Harvard’s Beth Israel Hospital. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional law and administrative law. She interned at the National Health Law Project and practiced insurance and health law. She teaches classes in the recognition of elder abuse and constitutional law for non-lawyers. She lives in Oakland, Ca.

Dear Friends & Colleagues,A common characteristic of the guests I invite on this podcast is their courage in and commitment to creating unprecedented positive change in healthcare. They don’t just do things right, they do the right things. And, while the content in these interviews centers on transforming healthcare, there are also lessons on humanistic leadership woven throughout. That’s not a coincidence because the act of reframing - of creative disruption - requires that type of leadership. Our guest this week, Secretary David Shulkin, exemplifies courageous, transformational, principled-based leadership. Dr. Shulkin served as a member of President Trumps’ cabinet, as the 9th Secretary of the US Department of Veterans Affairs. Previous to that he served under President Obama as Under-Secretary for Health. In both positions, he was confirmed by a unanimous Senate vote - an unusual testament to his competence and integrity. Prior to entering the government, Secretary Shulkin had a long distinguished career in the private sector. He served as CEO at Beth Israel Hospital in NYC and Morristown Medical Center in Northern NJ; and also held senior leadership positions at distinguished institutions such as the University of Pennsylvania Health System and the Hospital of the University of Pennsylvania. He has been named as one of the Top 100 Physician Leaders by Becker’s Hospital Review and one of the “50 Most Influential Physician Executives in the Country” by Modern Healthcare and Modern Physician. He has also been named by Modern Healthcare as one of the “One Hundred Most Influential People in American Healthcare”. Secretary Shulkin recently published a book entitled, ‘It Shouldn’t Be This Hard To Serve Your Country’, a memoir of his experience serving under two US Presidents. In this interview, you’ll hear:The important and unique role the VA system serves for military veterans, as well as its contributions to our larger healthcare system.The bold leadership maneuvers that Dr. Shulkin deployed to solve for immediate national VA healthcare crises and to navigate the entrenched culture of a slow moving and highly political bureaucracy.The lessons that Dr. Shulkin believes the US healthcare system can adapt from the VA.How Dr. Shulkin initiated the modernization of the VA system through the single largest electronic medical record (EMR) deployment in history.One of the major reframes that Dr. Shulkin introduced into the VA system, which was a shift from being a “pure provider of care” to becoming the “network coordinator of care”.The remarkable characteristics of Dr. Shulkin’s leadership approach are apparent in this episode. First - he focused on solving specific, patient-facing healthcare problems such as improving access to care and eliminating hepatitis C. Second - he fearlessly made decisions based on principles and evidence, followed with swift action. I say “fearless”because he was acting in a pathologically political environment, and many of the decisions he made were followed by highly publicized personal attacks on his character and integrity. Third - he focused on delivering measurable and meaningful outcomes, with a relentless push to transparency.  For me, the main story here is about a high-integrity, humanistic leadership approach coupled with a results-oriented, outcomes-based management style - singularly focused on creating unprecedented and differentiating value for patients and healthcare consumers. It seems ironic that we find one of the most brilliant examples of ‘consumer-obsessed’ leadership in the government-run VA system. Yet, there it is. I’d like to conclude these notes with a very personal message of gratitude.  I would like to sincerely and publicly thank our Veterans for their service and their sacrifice. I had the opportunity to spend the first seven years of my medical career providing care to Veterans at the Bronx VA Hospital in NYC. It was an experience that shaped my perspective and professional trajectory, leaving me with an indelible sense of humanistic mission and purpose.Until Next Time, Be Well.Zeev Neuwirth MD 

Does an Ultra-sound detect Endometriosis? Why do I still have so much pain after my surgery? Does pregnancy really cure Endometriosis? What are my options?Many Endometriosis sufferers have all these questions, but feel like no one, not even the medical professionals who we trust so much, can answer them. This is why I am so excited to be speaking to Dr Iris Orbuch in today's episode.Iris is an Endo Excision specialist and the Director of the Advanced Gynecologic Laparoscopy Center in Los Angeles and New York City. She operates at Lenox Hill Hospital, Mount Sinai and Beth Israel Hospital in New York City. She is one of the few physicians who understand that even though excision surgery is the gold standard for endometriosis treatment, the disease requires an integrative approach combining both Eastern and Western medicine to help patients heal and get them on the road to recovery. Infact, she just released a book called ‘Beating Endo’ with her co-author Dr Amy Stein. There is so much to learn from Iris today and it is an absolute honour to be interviewing her. So, sit back, relax and let’s have a listen!If you want to reach Dr Iris and know more, please visit her website www.lagyndr.com. You can also call the number on the website. Also make sure to buy her book, Beating Endo, which is now out. You can get it on www.HarperCollins.com or www.HarperCollins.co.uk and also on Amazon.If you enjoyed this episode, I would love to know. Join me on Instagram and Facebook. You can also join our community on Health Unlocked and ask any questions or share your stories.Don't forget to share and subscribe to this podcast.Till next time, remember, you are not defined by endo! Intro Music - Trip by KV https://soundcloud.com/kvmusicprod Creative Commons — Attribution 3.0 Unported — CC BY 3.0 http://creativecommons.org/licenses/by/3.0/ Music promoted by Audio Library https://youtu.be/uIqpcRPRy7sBreak Music - Funky Souls by Amarià https://soundcloud.com/amariamusique  Creative Commons — Attribution 3.0 Unported — CC BY 3.0  Free Download / Stream: http://bit.ly/Funky-Souls  Music promoted by Audio Library https://youtu.be/jFMCyqKF-EE 

Savage discusses Trump’s environmental policies and the damage that will be caused by them. Omar the Terrible is calling for the United Nations to come in and handle the border crisis for the United States. Savage says it’s time to get her out of office and put her on trial for sedition. Dr. Marilyn M. Singleton joins to talk Russia, Racists, and Ridiculousness … an interview Savage enjoys very much. Dr. Singleton is a board-certified anesthesiologist. She is President of the Association of American Physicians and Surgeons (AAPS). She graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at UCSF, then her Anesthesia residency at Harvard’s Beth Israel Hospital. While still working in the operating room, she attended UC Berkeley Law School, focusing on constitutional law and administrative law. Learn more about your ad choices. Visit megaphone.fm/adchoices

Wes received his Doctor of Chiropractic in 2014 from the University of Western States in Portland, Oregon. Before beginning clinical practice at Reebok CrossFit Back Bay and Brick CrossFit, he completed his clinical externship at Beth Israel Hospital's Spine Center. Currently, Wes is focusing in the area of training while injured. Both his patients and clients see exceptional results from his progressive blend of manual therapy and strength training.  Wes's background as an athlete includes competing in the CrossFit Regionals as an individual athlete as well as being a top finisher in the CrossFit Open.  Exclusive to WODcast listeners,  O2:  Use the code WODCAST for 20% off your first purchase at drinko2.com  DIRTY BIRD ENERGY : As a listener of Wodcast Podcast, DirtyBird Energy is offering you a special discount on their products! Use code WODCAST to save 20% on purchases of $20 or more at dirtybirdenergy.com.  Alpha Wolf Nutrition: Visit https://alphawolfnutrition.com/ and use WODCAST15 for 15% off your order.

Dr. Costas Hadjipanayis, Director of Neurosurgical Oncology for Mount Sinai Beth Israel Hospital discusses his experience working with the advanced robotically-controlled digital microscope, Modus V, from Synaptive Medical and how this technology was used recently to successfully remove a 19-year old woman's rare brain tumor.  Dr. H talks about the advantages to using this technology prior to surgery and during surgery, and how doctors need to think about embracing new devices and techniques to more accurately address medical challenges. @SynaptiveMed #BrainSurgery  #Neurosurgery  #PrecisionMedicine  #RoboticSurgery  #ModusV Synaptive Medical Listen to the podcast here.    

Dr. Costas Hadjipanayis, Director of Neurosurgical Oncology for Mount Sinai Beth Israel Hospital discusses his experience working with the advanced robotically-controlled digital microscope, Modus V, from Synaptive Medical and how this technology was used recently to successfully remove a 19-year old woman's rare brain tumor.  Dr. H talks about the advantages to using this technology prior to surgery and during surgery, and how doctors need to think about embracing new devices and techniques to more accurately address medical challenges. @SynaptiveMed #BrainSurgery  #Neurosurgery  #PrecisionMedicine  #RoboticSurgery  #ModusV Synaptive Medical Download the transcript here.

Tom Tinlin survived a brain aneurysm only to discover that more than half of the country has an aneurysm and may never even know it. Dan will be joined by Tim and Dr. Chris Ogilvey of the Brain Aneurysm institute at Beth Israel Hospital to answer your questions.

Dr. Chauncey Crandall IV, M.D.Dr. Chauncey Crandall IV is a world renowned Cardiologist practicing medicine in Palm Beach Florida, including clinics at the:Jupiter Medical CenterPalm Beach – Good Samaritan Medical CenterMount Sinai Heart New York – Palm BeachDr. Crandall has authored several books on faith, medicine and heart disease. His combination of faith and medicine to cure those in need has inspired millions.Dr. Crandall is currently Assistant Professor of Medicine at Mount Sinai Heart New York and also the Director of Preventive Medicine and Complex Cardiology at the Mount Sinai Heart New York–Palm Beach site in Palm Beach Florida. Dr. Crandall practices interventional, vascular, and transplant cardiology. Dr. Crandall received his post-doctoral training in Internal Medicine at Yale University School of Medicine where he also completed three years of research in the Cardiovascular Surgery Division. Dr. Crandall completed his Cardiology Fellowship training at Beth Israel Hospital and Mt. Sinai Medical Center in New York City and also completed advanced Interventional Cardiology Fellowship training at the Medical College of Virginia. Following his Interventional Fellowship training, Dr. Crandall remained at the Medical College of Virginia for six years as Assistant Professor of Medicine and as Chief of the Heart Transplant Program, Director of Medical Education and Director of Cardiac Critical Care.In 1993, Dr. Crandall accepted a Faculty Professor appointment at the Duke University School of Medicine Cardiovascular Division and relocated to Palm Beach, Florida where he established the Duke University Interventional Cardiology Program – Palm Beach. Dr. Crandall has continued his private and academic practice in the Palm Beach area, and is currently on staff at the Palm Beach Gardens Medical Center, Good Samaritan Medical Center, Jupiter Medical Center, and Icahn School of Medicine at Mount Sinai in New York.Dr. Crandall has lectured both nationally and internationally on topics to include: heart transplantation, interventional cardiology, preventive cardiology, cardiology health care of the elderly and also medical care to the poor in third world nations. Dr. Crandall is also Chairman of the non-profit Chadwick Foundation and devotes extensive time to missionary based medicine and education in the Caribbean, Africa, South America, Europe, and Haiti.In this interview Dr. Crandall shares some of the amazing stories of healing and raising the dead and also tells what some patients have experienced as life after death.

On this episode of Finding Your Frequency we are meet Dr. Marilyn Singleton, a board-certified anesthesiologist and President of the Association of American Physicians and Surgeons (https://aapsonline.org), to discuss healthcare today, what we read and the reality, patient centered medicine, and the fight for medical freedom. Dr. Singleton graduated from Stanford and earned her MD at UCSF Medical School. Dr. Singleton completed 2 years of Surgery residency at University of California at San Francisco Medical Center, then her Anesthesia residency at Harvard’s Beth Israel Hospital. Join us for this important, timely, and relevant healthcare interview with Dr. Singleton.

Despite being told, “they don’t take Negroes at Stanford”, Dr. Marilyn Singleton graduated from Stanford and earned her MD at UCSF Medical School. She then completed two years of surgery residency at UCSF, followed by an anesthesia residency at Harvard’s Beth Israel Hospital. In addition, she went on to first become an instructor, then Assistant Professor of Anesthesiology and Critical Care Medicine at Johns Hopkins Hospital in Baltimore, Maryland before she returned to private practice in California. While still working in the operating room, Dr. Singleton attended UC Berkeley Law School, focusing on constitutional law and administrative law.  She also interned at the National Health Law Program and has practiced both insurance and health law. Important lessons for everyone as we come to the end of Black History Month.  Dr. Singleton Bio    American Assoc Of Physicians and Surgeons  This Jouney Through Life

Michel Petrucciani, le piano en Majuscule (épisode1)   "Looking Up", le tube de la période américaine de Michel Petrucciani.   Michel Petrucciani a 36 ans lorsqu'il s'éteint des suites d'une infection pulmonaire, le 6 Janvier 1999 au Beth Israel Hospital de New-York. Avec Michel Petrucciani, c'est plus qu'un musicien qui disparaît: Une star, une icône et surtout un combattant. Atteint d'Ostéogénèse Imparfaite (la maladie des os de verre), Petrucciani a dû composer avec ce petit mètre qui faisait de lui une bizarrerie de la nature, alors qu'il était avant toute chose un excellent pianiste! Généreux, fort en gueule, jazzman jusqu'au bout des ongles, c'est grâce à une carrière menée à 100 à l'heure que Michel Petrucciani a pu prendre sa revanche sur la vie, lui qui était capable de jouer d'une seule main car son autre bras était dans le plâtre. 20 ans jour pour jour après sa mort, il est donc plus que temps de rouvrir le dossier Michel Petrucciani... Etagère n°8… Boite n°4… Dossier MP1962: Michel Petrucciani, le piano en majuscule (épisode 1)Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Rev. Michael JS.Carter is originally from Baltimore, Maryland. He moved to New York City in 1980 and lived there for 27 years, working as a professional actor before moving to Asheville. Michael is an ordained Interfaith Minister and received his BA Degree in Letters from the College of New Rochelle where he graduated cum laude. He received his Masters In Divinity Degree from Union Theological Seminary in New York City (class of 2000). He has served as a staff chaplain (Board Certified) at Lenox Hill Hospital, Beth Israel Hospital, Beth Israel Cancer Center, Methodist Hospital, and New York Hospital Queens while residing in New York City. A long-time UFO experiencer, he lectures extensively on the topic of religion and UFOs. He has appeared on the Sci-Fi Channel’s Steven Spielberg's production of Abduction Diaries, The Real 4400, and is a frequent guest on The History Channel’s production of Ancient Aliens, and UFO’s The Hidden Evidence which airs on The American Heroes Channel ( formally known as The Military Channel). He has also been interviewed by Academy Award winning actress Shirley MacLaine , George Noory's Coast to Coast AM, Beyond Belief on Gaia TV with George Noory, Contact In The Desert with Heather Wade, and Coast to Coast AM with Jimmy Church. Recently, Rev. Carter spoke at the International UFO Conference in Arizona in February 2018. In April of 2018, Rev. Carter spoke to Alabama MutualUFONetwork about Science, UFOs, and Religion. http://michaeljscarter.com

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnoses or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello. Welcome to "Cancer Stories." I'm Dr. Daniel Hayes, a medical oncologist, and translational researcher at the University of Michigan Rogel Cancer Center, and I've also been the past president of ASCO. I'll be your host for a series of interviews with the founders of our field. Over the last 40 years, I've been fortunate to have been trained, mentored, and inspired by many of these pioneers. It's my hope that through these conversations we can all be equally inspired, by gaining an appreciation of the courage, the vision, and the scientific understanding that led these men and women to establish the field of clinical cancer care over the last 70 years. By understanding how we got to the present and what we now consider normal in oncology, we can also imagine and work together towards a better future, where we offer patients better treatments and we're also able to support them and their families during and after cancer treatment. Today, My guest on this broadcast is Dr. Samuel Hellman, who is generally considered one of the fathers of modern radiation oncology in the United States and frankly, worldwide. Dr. Hellman is currently a professor emeritus at the University of Chicago Pritzker Medical School, where he served as the dean from 1988 to 1993. And he's been the A.N. Pritzker Professor of the Division of Biological Sciences. He's also served as the vice president of the University of Chicago Medical Center. Prior to moving to Chicago in the late 1980s, he had previously been physician in chief and the professor of radiation oncology at the Memorial Sloan Kettering Cancer Center. He served there from 1983 to 1988, and he was also chair of the Department of Radiation Therapy at the Harvard Medical School, where he served as the co-founding director of the Joint Center for Radiation Therapy. Dr. Hellman has authored over 250 peer-reviewed papers, and he's been one of the co-editors of one of the leading textbooks on oncology, Cancer, Principles and Practice. Dr. Hellman has won many awards and honors, including being named a fellow of the National Academy of Medicine, formerly the Institute of Medicine, and of the American Association for the Advancement of Science. He is frankly, one of the few individuals to serve as president of both the American Association of Cancer Research and the American Society of Clinical Oncology, for which he was actually, I believe-- correct me if I'm wrong Dr. Hellman-- the first radiation oncologist to hold that position, which he served in 1986 to 1987. Dr. Hellman, welcome to our program. Thank you for having me. I hope I got all that right. Your introduction has taken longer than some of the others. You have been so prominent in the field. I have a series of questions. The whole point of this is sort of like Jerry Seinfeld's Riding in a Cab with Friends. I've always said, if I had an opportunity to right with some of the giants in our field, what would I ask them during a cab ride? So I get to ask the questions, and you get to answer. I know you grew up in the Bronx. Can you tell us a little bit more about your background? I'm particularly intrigued about the fact that a boy from the Bronx ended up at Allegheny College in Pennsylvania. Why'd you go there? What was your interest? Was it always in science and medicine, or did you have something else in mind? OK. Well, start with the Bronx. I was born in 1934 in the Bronx in a nice part of the city, which doesn't often go with descriptions of the Bronx today, but it was at that time. And about well, 1950, which was when I entered my senior year in high school, I had gone to high school at DeWitt Clinton High School. And as I say, my senior year, we moved to Long Island, and I spent my senior year at Lawrence High School. The important part of this is that Clinton had about 4,500 to 5,000 boys, and Lawrence High School was much smaller and most importantly, coeducational, and that made me very much want to go to a smaller school for college and definitely one that was coeducational. And so my mother and I took a little tour of colleges not too far from New York, but Allegheny was the farthest, I think. It's in Western Pennsylvania, very close to the Ohio border. And it was a beautiful day. I had a very nice two people showing me around, and I became enamored of the place. It was a very good fit for me, but I must say, my method was not a very analytic one, but that's how I got to Allegheny College. And was science and medicine in your thoughts then, or did you have other things that you thought you'd do? No, no. I was a middle-class Jewish boy from the Bronx. You're programmed to be interested in medicine. The old comment was, you know what a smart boy who can't stand the sight of blood becomes? The answer is a lawyer. And I was not offended by the sight of blood. So I actually heard about your decision to go to SUNY Upstate Syracuse and the serendipity involved. And I'm always struck by how so many of us have what we plan and what we end up doing. Can you give us that story? I though it was really fascinating. Well, I'm not sure what part of it you want, but I went to Syracuse Upstate because I won a state scholarship, and I hadn't applied to any New York state schools. And fortunately, the medical school advisor and a former Alleghenian, who was at Upstate, arranged an expedited interview, et cetera. So anyway, that's why I ended there. Why I ended up in radiation oncology-- Well, that was my next question is, how did we get lucky that you decided to go into oncology? Well, I interned at Boston at the Beth Israel Hospital, which was essentially very oriented to cardiovascular disease. Our chairman was a renowned cardiologist. He was the first one to use radioactive tracers. He used radium, as it turned out, and there is an award given by the nuclear medicine society. Their big award, their annual award is the Hermann Blumgart Award, and Blumgart was my chairman. And Paul Zoll, the external defibrillator inventor, was there. Louis Wolff of Wolff-Parkinson-White syndrome was there. So it was a cardiac place. And internal medicine was what I wanted to do, but my father was quite hard of hearing and had a lot of trouble making a living, because he was so impaired. And electronic devices, of course, weren't available at that time. And it was widely thought that otosclerosis which is what he had, was a hereditary disease. And so I was discouraged somewhat from entering medicine, not being able to be sure I could use a stethoscope. Parenthetically, I have never had any trouble, and the disease is no longer thought to be hereditary but rather the sequelae of infectious diseases, either diphtheria or influenza. This was the great influenza epidemic. The two, one of those two. But anyway, that's what he had, so I sought to do something else. And I was a little bit put off by taking care of disease which we really could not alter the course of. We could modify it. We could palliate, but probably if I were more dexterous, I would have become a surgeon. But I wasn't, and so I decided I didn't know what to do. I'd take a radiology residency and see where that led. This was late in the year, and there were no radiology residences, literally, in Boston that were available. But a new chief had come to Yale, and he was starting a new program. And one of radiologists in a neighboring institute told me go there. So I did. Well, he turned out to be a radiation oncologist, and he, Morton Kligerman and Henry Kaplan, were the two chairmen of departments of radiology who were radiation oncologists. And Henry had been at the NIH and got them to, with the National Cancer Institute, I guess, to start a fellowship program to encourage radiation oncology. And Kligerman applied for one, got one. I was there. I was captivated by the opportunity to do some curative treatment. I was a chemistry major in college, and physics and chemistry were things I enjoyed. Sounded like a good choice, so that's what happened. So there could not have been very many specific radiation oncology fellowship programs at that time in the United States. Is that true? Yeah, very much true. The ones that stood out was, I say, Henry Kaplan's. There was a very good one at UCSF. And there was one in Penrose Cancer Hospital and one at the MD Anderson, and those were the ones. So your decision to go oncology then, really your decision to go into radiology-- diagnostic radiology originally, sorry-- didn't sound like you were-- Not really. I took a radiology residency, because I thought it would be helpful whatever I decided to do. I really didn't expect to go into diagnostic radiology, but I figured that's something I could do. I didn't have much training or any training in that before. There was a great dynamic radiologist at the Beth Israel Hospital, and he captivated me. And so I figured, there's a lot to learn there, and I'll try it. I think a lot of the younger doctors don't realize that the two were together for a long time. What's your perspective of the split between diagnostic and therapeutic radiology-- I've actually heard you talk about this, so I think I know what you're going to say-- and bringing them back together? Well, I was a great proponent of it. The whole fields are entirely different. But having diagnostic radiology is extremely helpful in radiation oncology, because we depend on images to determine how we treat, where we treat, and so forth, so it was there. But they were interested in entirely different things. And just parenthetically, when I took the Harvard job, I wasn't going to take it unless I had a promise that we could start a Department of Radiation Oncology. Shortly after I came, and the decision was made with just a shake of the hand that, after a year or two, I'd be able to do that, and that's what happened. Actually, that segues into another question I had is I was looking over your background. I met you first when I was a first-year fellow at the medical oncology. That was 1982, by the way, a long time ago, when it was still the Sidney Farber. And I'd heard about your legendary efforts starting the Joint Center and also your teaching methods with your own residencies. But you were rubbing shoulders with Sidney Farber and Francis "Franny" Moore and Tom Frei. That must have been pretty intimidating for a relatively young guy trying to start a whole new department. What was the impetus behind that? It was an interesting experience. Dr. Farber was, of course, the dominant figure in cancer at Harvard, and nationally, he was one of, if not the great leader. I mean, but he was a difficult man, and I don't like to speak disparaging, but we had a rocky relationship. When the Joint Center-- I'm getting ahead of my story, but it's appropriate to this question. When the Joint Center was started, it was started by Harvard Medical School, and the dean for hospital affairs was a man named Sidney Lee. Dr. Lee had formerly been the head of the Beth Israel Hospital, the director, not the chairman of medicine but the director. And he got the idea that all the hospitals in the Harvard area were relatively small, the Mass General was across town and quite large, but that was not true for the Brigham or the BI or the Deaconess or what at that time was the Boston Hospital for Women. And so he got them all together. So there were those, and I think I left out the Children's, but Children's was amongst them, as well as the Sidney Farber, as you say. Or at that time, it wasn't called that. It was called the Jimmy Fund, but that's another story, and one you know better than I, I suspect. But anyway, those six were to get together when I started the Joint Center. Because Dr. Farber and I had so much difficulty with each other-- he wanted really for me to be reporting to him and being part of the Jimmy Fund but that wouldn't have worked with the other hospitals. He was not liked by any of the places, including Children's, which is where he was the pathologist. So those six initial institutions, when we finally came to sign, turned out to be only four because the Children's wouldn't come in, and the Jimmy Fund wouldn't come in. For a number of reasons, two years later, they acquiesced, mostly because we were successful, and they were without supervoltage treatment, and it was just not sensible for them not to join. But that's my relationship with Sidney. Franny Moore is a different story. Franny Moore was an internationally-known surgeon and expected to have his way, but he was very graceful, very nice. I had very few disagreements with him. He expected, and I think, deserved certain deferences. Sydney did, too, but it just made it too difficult to do that but Franny was not that way. Franny and I came to the treatment, conservative treatment of breast cancer from different points of view. He didn't agree with it, but he was entitled to his opinion, and he was fine. Tom is a different story. I got there ahead of Tom, and he came, and if anything, I helped out Tom, although he was much senior. Harvard has its own culture, as you know, and he needed at least an introduction. I mean, he sailed along fine after that. And in fact, at one time, he and I wanted to start a joint residency program. It was to be a four-year program, which would have people take two years together and two years in their respective specialty. But the boards were not in agreement, so it was dropped. But Tom and I always got along fine. Actually, that raises one of my other questions. I spent a lot of time in Europe, and the field of so-called clinical oncology still remains, combining radiation and medical oncology. In fact, they style it as a particular specialty in Great Britain. How did it evolve not that way in the United States? Radiation oncology went off on its own. And I think you had a lot to do with really professionalizing radiation oncology as a specialty in this country. Is that not true? I'd be interested in your perspectives on this, too. Well, I should parenthetically say that I spent a year in the National Health Service in 1965, while I was a fellow at Yale, in clinical oncology at the Royal Marsden Hospital, their major teaching hospital for cancer. And I always believed in the joint efforts of a non-surgical oncology program. You can include the surgeons, mostly because their lives are so different and their technical training is much more extensive, but you can work closely with them, and I've been fortunate to be able to do that. But medical oncology and radiation, in my judgment, would be better off close together. And your comment about me and ASCO, being the first president as a radiation oncologist, and I never call myself a radiation oncologist, at least not initially. I always call myself an oncologist. But I do, I agree and then describe what I do as radiation. But I agree with you, they have the best title-- clinical oncologists. And why it occurred the way it occurred, I'm not sure. I know we started in radiology and medical oncology started in hematology. I mean, the real revolution, and leaving aside Dave Karnofsky and his work, the real changes occurred in acute leukemia. And the real founders of the specialty, Dave was surely one of them, but a great many of them were all hematologists, leukemia doctors, and it grew from there. It grew out of hematology. And a lot of major oncology papers were in Blood, the journal Blood before they were in JCO. So that's the best I can do with it. Our big thing was to separate from diagnostic. Getting closer to medical oncology is much easier, because we have the same book. You said I wrote the textbook with Vince and Steve, and so I did. And that was very easy. We spoke the same languages. We saw the same things, not completely. I saw more head and neck. Vince saw more of the hematologic malignancies, but the rules were similar. It was no-- it was easy. And I've heard Dr. Frei-- I trained with him when he was alive and obviously, Dr. DeVita talked about what it was like to give chemotherapy when they started. And how we really professionalized, in many ways, and split up giving chemotherapy, the different responsibilities. What was it like with radiation oncology back 40 years ago? I mean, how did you-- the safety issues, were you all cognizant of the safety issues related to radiation at the time? How did you do your planning? What was that like? Well, safety was-- Hiroshima made everybody know a lot. In fact, if anything, we were more conservative than we probably needed to be because of radioactivity being an evil and all the things that happened after '45 and at Hiroshima and Nagasaki experience. And so safety wasn't a problem that way. But there were a lot of people in the field who were using the field, who are not radiation oncologists. Some of them were radiologists, diagnostic radiologists and did it part time. They had a cobalt unit, before that, just an orthovoltage, conventional energy, much less effective and more damaging. And also gynecologists, and when I visited Memorial Hospital early on in my training, and the surgeons would send a prescription blank, a regular prescription dying down to the radiation therapist. And that's what they were, technicians, or often were. And they may have differed with the prescription but only by being careful and discussing it with the surgeons and convincing them that some change should be. That's very different. How was the planning done? How was the planning done? The planning was fairly primitive. Well, most places had a physicist, usually a physicist, who did both diagnostic machines and conventional radiation oncology, and they were important in that department and those people subspecialized, too. And in fact, when I came to Boston in 1968, Herb Abrams, who was the new chairman of radiology-- he's the one who chaired the committee that selected me-- but he and I jointly started a physics department. So it was still in diagnosis as well as therapy, but we realized that wasn't a good idea and separated. So physics was evolving, but treatment planning before supervoltage, and even with supervoltage before multileaf collimators and a lot of the newer, what then were newer techniques, was reasonably rudimentary. When I did my residency, we did our own planning, and usually, it got checked by the physicist but not all the time. It's a lot different now. Yes, it is. I want to turn this to an area that's more personal to me and that is your role, out of all the many contributions you've made to the field, your role in the field of breast-preserving therapy. I came in just as you and Jay Harris were really making that institutionalized. Just for our listeners, what were the hurdles there? They must have been both personal and professional and technical. And did you ever doubt that this be successful in the long run? You must have had some second thoughts about getting into this. Well, I have to back up. It was well before Jay, but it was at Yale. And apropos of how many-- going back to our previous question-- how few radiation oncologists there were. There was a club. Before there was a specialty, before there was a society, there was the American Club of Radiation Therapy. And all you had to do to belong to it was do radiation therapy without doing diagnostic radiology. And I was in the low 200ths of the consecutive order of people who belonged to the specialty from its very inception at the turn of the century. So there were very few of us, and we knew each other extremely well and had these little conversing meetings. And a number of people would talk about patients who had medical diseases which wouldn't allow them to have their breasts removed. They still had localized, apparently localized breast cancer, and the radiation therapist took care of them, and I did, too. I had these people. And we also had the Europeans, especially the French, who were treating breast cancer with radiation. In fact, they were doing it with a fundamental difference with what we did from the beginning and they do now. And that is, they did it without removing the breast cancer, because they were doing it primarily for cosmetic reasons. And they felt that taking out the breast cancer might damage the cosmetic effect. So we weren't alone. We weren't first. So I knew that other people had done it. Some people who did, Simon Kramer in Pennsylvania at Jefferson, Thomas Jefferson, did a great deal of it. And we did it, because we had a surgeon at Yale who was interested in sending patients. You mentioned Jay, but really, before Jay, there was Lenny Prosnitz, who you may or may not know of, who was a long-time chairman at Duke. But Len was a medical oncologist at Yale, who was about, I don't know, three or four years behind me in training, and I was either a young assistant professor there at the time or a fellow, I can't remember which. And he came over to me and said, you've got a nice life. You do interesting things. I'm not so crazy with this. Can I get into it? And Lenny, obviously, being trained in medical oncology, being a boarded internist was also interested in breast cancer. Because that's the one disease, even in the beginning that medicine, or one of the few diseases that medicine was interested in for the hormonal aspects of the disease. So Lenny took over when I left with the surgeon Ira Goldenberg, and he kept it up. And when I went to Harvard, I had all those different hospitals, and I had a very good colleague there, who was the only radiation oncologist in those hospital complex, and he also treated some. So we continued to do it. One of the nice things about Harvard at that time was, at least for this purpose, was we had this women's hospital, Boston Hospital for Women. And gynecologists in those days did everything for women and that included breast surgery. And those guys delivered their babies and when they got breast cancer, took care of them. They weren't interventional. They were their private primary care docs, and they were much more sensitive to the cosmetic aspects and the self-image aspects of breast cancer surgery. And so they knew we did it, and they became a big source of suggesting patients and sending them to us. Anyway, Marty, Marty Levine, the fellow I was talking about, and I developed a reasonable number of them. One of my residents, Eric Weber said, why don't you write a paper about this? I said, it's all done. The French have it. The Brits have it. Even the Canadians have it. He said, we don't. So I said all right. We sent out the paper, and the first paper is with Eric and Marty and me, and it was a JAMA paper and that gets to another point. What year was that? I had to bully pulpit. What year was that, the JAMA paper? The JAMA paper? About '75-- '74, '75. And it made a big splash. And then Lenny and Simon Kramer and Luther Brady, two Philadelphia people who had big experience, and us put all of our stuff together. And Lenny brought it all together, and so there was another big paper. I think that one was in JCO, but maybe not. I can't remember. And I think that's how it got started. And my issue with it and my involvement in it is, yes, pioneering the treatment in America. I don't claim to have pioneered it anywhere else. It wouldn't be true. But what I did do is use the bully pulpit of being the Harvard professor, and I went everywhere and talked about it. And I took on the surgeons in a number of places and talked about it. And if I made a contribution to it, it was that. I can remember being in an audience and hearing you talk about the Halstead theory and then the Fisher theory and what became known, in my opinion, as the Hellman theory, which is a combination of the two. That both local and systemic therapies make a difference, and the mortality rate of breast cancer has dropped by almost one-half over the last 30 years, and you should be proud of that. Oh, I'm proud of it. I'm proud of it. But people don't do things in a vacuum. You build on people and on their doings. Well, I want to be respectful of your time, if I can finish up here. I really just touched the surface of many of the contributions you've made. I wanted to talk a little bit about your role in getting radiation oncologists to think about what we now call translational science. But at the end here, what do you think are your greatest accomplishments? What do you think your legacy has been to the field? Do you think it's the science or your administration or your teaching and mentoring or all of those together? I think all of us would like to think about what our legacies would be. Oh, I would say, it's an interesting and not an easy question, because I'm interested in all of those things. But I like to remind people that, and it's been commented on by others, I am one of the few people who maintained a practice of medicine, a real practice, all through being a dean. I always think of myself first as a doctor. And I am an investigator, and I am interested in research, both basic and clinical, and did both of them, but I'm a doctor first, that's number one. Second to that, I was very involved in teaching and believe-- and that's why I became a dean and before that, started a department in Harvard and gave courses in oncology, and my residents are my greatest legacy, if you really want to know. Nobody lives forever, and what you did in the lab and your patients, that passes, but your residents are your history. They continue it, and their residents continue it and so forth. And just to end on a high note that you mention, is that the Karnofsky lecturer this year was one of my residents. Yes, he was. Of course, that's Ralph Weichselbaum. He was. I actually chaired the selection committee, and I can't tell you how proud I was to stand up and introduce him. He did a wonderful job. In addition to your own residents, I'm going to tell you, you're also passing this on to the medical oncology fellows who were hanging around the Farber in those days. And to this day, I tell patients I wear two hats. My first hat is to take care of them as I can with the knowledge I have today, and my second hat is to do research to make it better. But my first hat always wins, because Dr. Hellman said you're a doctor first. So there you go. Well, I haven't changed on it. That's very nice to hear though. OK. I think on that note, we'll end up. I had planned over about half an hour. We're just over that. So thank you very much, both from me, personally, and from those of us in the field and from our patients who have benefited. Dr. Hellman, you are truly a pioneer and a giant in our field. So thank you so much. Well, you're very kind to say so. For more original research, editorials, and review articles, please visit us online at jco.org. This production is copyrighted to the American Society of Clinical Oncology. Thank you for listening.

TURNING YOUR DREAMS INTO REALITY   What does it take to begin turning your dreams into reality?  It takes sacrifice, grit, and time. Creating time comes by evaluating priorities and eliminating anything that is not supporting your goal.   Dr. Scott Colonna is the first person in his family to graduate from college, but hard work and sacrifice were foundational in his upbringing.  He had to make a decision to sacrifice something in order to make his dream of business consulting become a reality. He set aside an easier path, and instead followed his passion for consulting.     Dive in to find out how you can begin turning your dreams into reality. TOPICS DISCUSSED TODAY Creating Time Sacrificing Working hard Finding solutions Delegating Building Relationships SCOTT SAID:   “we always want to be in a position to be able to help [clients] help their families”   “when you have that passion inside you, it doesn’t just stop at a certain time.  It overflows to your family”   “most people’s goals are very small. . .  I always proceed with, “Well, what’s you bigger goal?”   “I want to hire people in our companies that can bring new ideas and solutions to the table”   “I don’t undervalue experience” ABOUT DR. SCOTT   “Dr. Scott A. Colonna is a senior partner at Uppercut Consulting and Westminster Eyecare Associates. He is a native of New York City and received his Doctor of Optometry degree from the State University of New York College of Optometry in Manhattan, New York. He completed his Bachelor’s Degree in Biology from Lafayette College in Easton, PA. Dr. Colonna completed internships in primary care and ocular disease at the Veterans Affairs Medical Center in Newington, CT and infant and pediatric care at Beth Israel Hospital and SUNY in Manhattan, NY. While in optometry school he traveled with the Volunteer Optometric Services to Humanity organization to provide eye care in Nicaragua. He has also been part of the Special Olympics Opening Eyes program which provides free eye exams to participants of the Special Olympics. Dr. Colonna has extensive experience in pediatric and infant eye examinations, primary care, contact lens, geriatric care, and ocular disease. He is an active member of Infant See, the American Optometric Association, and the Rhode Island Optometric Association. Dr. Colonna has been practicing in Rhode Island since 2001” (UpperCut Consulting.Com). FINAL THOUGHTS ON TURNING YOUR DREAMS INTO REALITY Plan for the marketing purposes and market your platform and get the word out sooner rather than waiting until everything is set up.     CONNECT WITH DR. SCOTT   Facebook: Scott Colonna Web: UpperCutAdvantage.com  

Recorded at the Birdman Studio. In this episode Birdman chats with Dr. George Paik, MD, who is a new Cardiologist with Summit Healthcare.   Video @ https://youtu.be/SwkhqEvjCCE   About Dr. George Paik, MD:   George Paik, MD, is a board-certified in Cardiology and Interventional Cardiology. He graduated from the University of Chicago and completed his internship, residency, and fellowship at Beth Israel Hospital in Boston, Massachusetts. He is a Fellow of the American Collage of Cardiology.   Dr. Paik chose Cardiology as his specialty as it allows him to utilize many aspects of his medical and pre-medical education. His practice philosophy is to put the patient first and always practice evidence based medicine. He has a special interest in Coronary Artery Disease, Congestive Heart Failure, Cardiac Arrhythmias, and Preventive Cardiology.   In his spare time he enjoys skiing and golf.       Visit: https://summithealthcare.net/   Summit Cardiovascular Services, 5171 Cub Lake Rd, Show Low, AZ 85901.  (928) 537-9944

Ray Noble talks to Samuel Shem, the acclaimed author of The House of God. The House of God, published in 1978, has in many ways become a cult book in the medical profession. It follows a group of medical interns at Beth Israel Hospital over the course of a year in the early 1970s, focusing on the psychological harm and dehumanization caused by their residency training.  For this dialogue we took the opportunity to catch up with Samuel Shem when he visited Oxford last year.  We hope to have a more extensive interview with Samuel Shem in the near future. 

Kathryn interviews Andrew E. Budson MD, author of “Seven Steps to Managing Your Memory: What's Normal, What's Not, and What to Do About It”. How can we differentiate between normal and abnormal memory changes, in loved ones and ourselves? From misplacing our keys to recalling a new acquaintance's name, memory dominates everyday life. Dr. Budson is a lecturer in neurology at Harvard Medical School, professor at Boston University School of Medicine. Kathryn also interviews lawyer, doctor, and former congressional candidate Marilyn Singleton MD, JD. Dr. Singleton combines her experience as a board-certified anesthesiologist with her education in constitutional and administrative law to analyze the current heath care environment, exposing the lobbyist interests of pharmaceutical companies and insurance providers. She graduated from Stanford U and UCSF Med School completing her anesthesia residency at Harvard's Beth Israel Hospital.

Kathryn interviews Andrew E. Budson MD, author of “Seven Steps to Managing Your Memory: What's Normal, What's Not, and What to Do About It”. How can we differentiate between normal and abnormal memory changes, in loved ones and ourselves? From misplacing our keys to recalling a new acquaintance's name, memory dominates everyday life. Dr. Budson is a lecturer in neurology at Harvard Medical School, professor at Boston University School of Medicine. Kathryn also interviews lawyer, doctor, and former congressional candidate Marilyn Singleton MD, JD. Dr. Singleton combines her experience as a board-certified anesthesiologist with her education in constitutional and administrative law to analyze the current heath care environment, exposing the lobbyist interests of pharmaceutical companies and insurance providers. She graduated from Stanford U and UCSF Med School completing her anesthesia residency at Harvard's Beth Israel Hospital.

Dr. Maurice A. Salama completed his undergraduate studies at the State University of New York at Binghamton in 1985, where he received his BS in Biology. Dr. Salama received his DMD from the University of Pennsylvania School of Dental Medicine, where he later received his dual specialty certification in Orthodontics and Periodontics, as well as implant training at the Branemark Center at Penn. He was awarded the George Coslet and Richard Chase Scholarships at the University of Pennsylvania during his post-doctoral studies. Dr. Salama is currently on the faculties of the University of Pennsylvania and the Medical College of Georgia as Clinical Assistant Professor of Periodontics. Dr. Salama has completed an ADA accredited hospital-based General Practice Residency at Maimonides Medical Center in New York City. In 1988 he had the opportunity to further broaden his clinical horizons through externships at Hebrew University in Jerusalem and Beth Israel Hospital in New York City. His very unique background includes specialized training in Orthodontics, Periodontal Surgery, and Implant Dentistry. Dr. Salama is an active member in the American Academy of Orthodontics, the American Academy of Periodontics, the Academy of Osseointegration, Alpha Omega International Dental Fraternity, Thomas P. Hinman Dental Society, Georgia Dental Association, and the American Dental Association. He also served as the Dental Expert for Fox (WAGA) TV in Atlanta, Georgia on a weekly basis. The dual nature of his specialty training makes Dr. Salama a frequent author of dental literature, and a sought-after lecturer nationally and internationally. http://www.dentalxp.com

Intel Shift changes directions on this high impact conversation with 3 top thought leaders on analytics and AI. In this show Dez Blanchfield, Intel’s Bob Rogers and Montefiore MD Michelle Gong soundoff on AI and Analytics. Starting off with a discussion around the advances that have taken place in analytics over the past 5-10 years followed up with some insights from Bob Rogers, a Harvard phD on the differences between advanced analytics and AI. The conversation then turned to Dr. Michelle Gong who shared some fascinating ways the hospital is utilizing advanced analytics to improve patient care. One example included using data identifiers to better predict when patients would require the assistance of a clinician. The episode concludes with some best of breed advice from the panel on how to apply analytics and AI into your business today. Tune in to hear these great insights and more. Dez Blanchfield, Chief Data Scientist, Gara Guru As an Industry Analyst, Business & Technology Consultant, covering Digital transformation, Cloud, Big Data & Analytics, Internet of Things, Machine 2 Machine, Cyber Security, Cyber Risk & Resilience & Smart Cities, Dez has invested his professional career of some two and a half decades thinking out and influencing the development roadmaps of technology companies, aligning them to the customer experience demands and possibilities of forward thinking digital enterprises. He sits on and works with boards of government and private sector organisations, to help uplift the digital quotient of organisations as a thought leader and practitioner across a broad range of disruptive technologies. He enjoys assisting organisations to disrupt themselves before being caught on the back foot by emerging new entrants or competitors. Passionate about leveraging the possibilities of new and emerging technology business, he is currently focused on bringing the likes of Cloud, Big Data & Analytics, Machine Learning, Cognitive Computing, Robotic Process Automation, Cyber Resilience, Blockchain and Agile DevOps to organisations to ensure their enduring success. Michelle Ng Gong, MD, MS, Director of Critical Care Research, Division of Critical Care Medicine, Jay B. Langner Critical Care Service Department of Medicine, Montefiore Medical Center Dr. Gong is the Associate Director for Academic Affairs, the Director of Critical Care Research in the Division of Critical Care Medicine at Montefiore Medical Center and Professor in Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master’s degree in Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine. She joined the Einstein/Montefiore faculty in July 2009. Dr. Gong is recognized nationally and internationally for her expertise in critical care research. A model clinician-researcher, her scientific projects influence her clinical care, and her patients influence her research. Her overall research focus has been on the prediction and prevention of acute critical illness and their complications. Continuously funded by the NIH for over 16 years for her research, her current projects range from acute respiratory distress syndrome (ARDS) to prevention of delirium, treatment of severe influenza and the development of new electronic acute care interfaces. Bob Rogers, PhD, Chief Data Scientist, Big Data Solutions, Data Center Group Bob Rogers, PhD, applies his experience solving problems with big data and analytics to help Intel build world class customer solutions. Prior to joining Intel, Bob was co-founder and Chief Scientist at Apixio, a big data analytics company for healthcare. He believes that accurate understanding of patient clinical and genomic data, physician behavior, and the characteristics of the healthcare delivery network are foundational to a better future for healthcare, and that Big Data analytics is essential to driving this transformation. Bob began his career as an astrophysicist, developing computer models of physical processes near super-massive black holes. He became interested in computational intelligence and incorporated research on artificial neural networks into his academic work. He co-authored the book “Artificial Neural Networks: Forecasting Time Series,” which led to a twelve-year career managing a quantitative futures trading fund based on computer models he developed. In 2006, Bob transitioned into healthcare at Carl Zeiss Meditec, where he was responsible for new product development for the diagnostic device that is the global standard of care for glaucoma. He received his BS in Physics at UC Berkeley and his PhD in Physics at Harvard.